Sentence,class,file
"Surgical Neurology International 2014, 5:45  http://www.surgicalneurologyint.com/content/5/1/45margins probably represent a less aggressive subset of  lesions, as shown in high grade extremity sarcomas.",Non-OADS,/arxiv_data1/oa_pdf/e4/f3/SNI-5-45.PMC4014828.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial A Tribute to Atos de Sousa, MD Gilbert Dechambenoit, James I. Ausman CMCO Côte d'Opale; Boulogne, France E‑mail: Gilbert Dechambenoit ‑ gdechambenoit@gmail.com, *James I. Ausman ‑ jia@surgicalneurologyint.com   *Corresponding author Received: 13 February 14  Accepted: 13 February 14  Published: 29 March 14 On November 17, our friend and colleague, Atos Alves de  Sousa, M.D., Ph.D., Honorary President of the WFNS,  Professor and Chairman of Neurosurgery, Santa Casa  and Lifecenter Hospitals, Belo Horizonte ‑ Minas Gerais,  Brazil, passed away during the night from a fulminant  heart attack.",Non-OADS,/arxiv_data1/oa_pdf/cf/ff/SNI-5-44.PMC4014829.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/44/129700 Copyright: © 2014 Dechambenoit.G.,Non-OADS,/arxiv_data1/oa_pdf/cf/ff/SNI-5-44.PMC4014829.pdf
"Surgical Neurology International 2014, 5:44  http://www.surgicalneurologyint.com/content/5/1/44Atos was one of the founding members of Surgical  Neurology International  as his international travels told  him that people everywhere would like a free journal that  they could access anytime, because many did not have  this information.",Non-OADS,/arxiv_data1/oa_pdf/cf/ff/SNI-5-44.PMC4014829.pdf
Available from: http://www.ratbehavior.org.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/ABR-3-104.PMC4014830.pdf
10. http://en.wikipedia.org/wiki/Baygon.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/ABR-3-104.PMC4014830.pdf
11. http://en.wikipedia.org/wiki/Baygon.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/ABR-3-104.PMC4014830.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Urgent treatment of severe symptomatic direct carotid cavernous  fistula caused by ruptured cavernous internal carotid artery  aneurysm using high‑flow bypass, proximal ligation, and direct  distal clipping: Technical case report Hirotaka Hasegawa, Tomohiro Inoue, Akira Tamura, Isamu Saito Department of Neurosurgery, Fuji Brain Institute and Hospital, 270‑12 Sugita, Fujinomiya‑shi, Shizuoka 418‑0021, Japan E‑mail: *Hirotaka Hasegawa ‑ ayhi_hase_dani@yahoo.co.jp; T omohiro Inoue ‑ t.inoue‑fujinsu@beige.plala.or.jp; Akira Tamura ‑ tamura‑nsu@umin.ac.jp;   Isamu Saito ‑ saito‑kyr@umin.ac.jp   *Corresponding author Received: 10 February 14  Accepted: 06 March 14  Published: 15 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130772  Quick Response Code: Abstract Background: Direct carotid cavernous fistula (CCF) secondary to ruptured  carotid cavernous aneurysms  (CCAs) is rare, but patients with this condition who  develop acutely worsening and severe neuro‑ophthalmic symptoms require urgent  treatment.",Non-OADS,/arxiv_data1/oa_pdf/c4/d4/SNI-5-49.PMC4014831.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/49/130772 Copyright: © 2014 Hasegawa H.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c4/d4/SNI-5-49.PMC4014831.pdf
"Surgical Neurology International 2014, 5:49  http://www.surgicalneurologyint.com/content/5/1/49which case direct surgical trapping of the lesion and distal  bypass might be indicated.",Non-OADS,/arxiv_data1/oa_pdf/c4/d4/SNI-5-49.PMC4014831.pdf
"Surgical Neurology International 2014, 5:49  http://www.surgicalneurologyint.com/content/5/1/49MR imaging revealed no significant cerebral infarction  in the revascularized distal right ICA area and showed  marked shrinkage of the formerly engorged left  SOV [Figure 2d‑f].",Non-OADS,/arxiv_data1/oa_pdf/c4/d4/SNI-5-49.PMC4014831.pdf
"Surgical Neurology International 2014, 5:49  http://www.surgicalneurologyint.com/content/5/1/49excessive packing of coiling material into the cavernous  sinus might aggravate visual symptoms.",Non-OADS,/arxiv_data1/oa_pdf/c4/d4/SNI-5-49.PMC4014831.pdf
"Surgical Neurology International Editor: Michel Kliot,  MD UCSF Medical Center   San Francisco, CA 94143OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neurosurgical Developments on the Horizon, a supplement to SNIS49What do hotels and hospitals have in common?",Non-OADS,/arxiv_data1/oa_pdf/ff/3c/SNI-5-49.PMC4014833.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/3/49/128913 Copyright: © 2014 Zygourakis CC.,Non-OADS,/arxiv_data1/oa_pdf/ff/3c/SNI-5-49.PMC4014833.pdf
The sequences obtained were submitted to the MLST da- tabase (available at: http://www.mlst.net ) and assigned a se- quence type (ST).,OADS,/arxiv_data1/oa_pdf/cd/59/jit481.PMC4014860.pdf
"ORs and 95% con ﬁdence inter- vals (CIs) were calculated using the Fisher method implement- ed in the Epitools package for statistical software R, version 2.13.0 (available at: http://www.r-project.org ).",OADS,/arxiv_data1/oa_pdf/cd/59/jit481.PMC4014860.pdf
14.http://spneumoniae.mlst.net/ .,Non-OADS,/arxiv_data1/oa_pdf/cd/59/jit481.PMC4014860.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution licence http://creativecommons.org/licenses/by/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/74/3f/S1368980013003133a.PMC4014862.pdf
Acknowledgements Sources of funding: The work was funded via the National Prevention Research Initiative http://www.npri.org.uk(grant number 87122).,Non-OADS,/arxiv_data1/oa_pdf/74/3f/S1368980013003133a.PMC4014862.pdf
London: The Marmot Review; avail- able at http://www.instituteofhealthequity.org/Content/ FileManager/pdf/fairsocietyhealthylives.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/74/3f/S1368980013003133a.PMC4014862.pdf
http://new.wales.gov.uk/topics/educationandskills/schoolshome/foodanddrink/breakfast/?lang 5en (accessed August 2013).,Non-OADS,/arxiv_data1/oa_pdf/74/3f/S1368980013003133a.PMC4014862.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/58/2a/srep04906.PMC4014880.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4906 | DOI: 10.1038/srep04906 7",Non-OADS,/arxiv_data1/oa_pdf/58/2a/srep04906.PMC4014880.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c8/e0/srep04897.PMC4014881.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4897 | DOI: 10.1038/srep04897 8",Non-OADS,/arxiv_data1/oa_pdf/c8/e0/srep04897.PMC4014881.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/01/9d/srep04905.PMC4014883.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4905 | DOI: 10.1038/srep04905 8",Non-OADS,/arxiv_data1/oa_pdf/01/9d/srep04905.PMC4014883.pdf
"http://www.columbiamedicine.org/divisions/gharavi/cal c_genetic.php).Table 3 |Risk of susceptibility to IgAN based on uwGRS GRSMean Cases vs. ControlsDifference value in meanMedian Cases vs. ControlsDifference value in median OR (95% CI) p Adjusted OR (95% CI) p uwGRS5 8.00/7.29 0.71 8/7 1 1.22 (1.16–1.28) 9.73 3102171.21 (1.15–1.27) 2.24 310214 uwGRS7 11.29/10.36 0.93 12/11 1 1.24 (1.19–1.30) 1.01 3102221.24 (1.19–1.30) 5.19 310220 uwGRS9 13.45/12.38 1.07 14/13 1 1.24 (1.19–1.29) 2.23 3102251.23 (1.19–1.29) 6.11 310222 uwGRS4 5.45/5.09 0.36 5/5 0 1.30 (1.21–1.40) 1.04 3102111.29 (1.19–1.40) 2.28 310210 OR in this table represents the expected change in odds of a case being associated with a 1-unit increase in the GRS, as determined by logistic regressio n of case/control status on GRS.",Non-OADS,/arxiv_data1/oa_pdf/5f/82/srep04904.PMC4014895.pdf
"Although poweranalysis indicated that we had about a 0.6–0.8 power to detect a two- fold increased risk considering clinical parameters and disease progression, assuming an a-level of 0.05 and allele frequency of 10%–30% (http://biostat.mc.vanderbilt.edu/PowerSampleSize), theeffect size identified was far smaller than two and all the associationsdid not survive multiple testing.",Non-OADS,/arxiv_data1/oa_pdf/5f/82/srep04904.PMC4014895.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4904 | DOI: 10.1038/srep04904 9",Non-OADS,/arxiv_data1/oa_pdf/5f/82/srep04904.PMC4014895.pdf
"Maps were created using Mapinfo software; data are from the National Fundamental Geographic Information System (NFGIS) website (http://ngcc.sbsm.gov.cn/).Table 1 |Numbers of different mosquito species collected at 3 sites in Shandong, China in 2013 SpeciesCollection sites Total (%) Junan Kenli Rongcheng Aedes albopictus 30 570 28 628 (4.3) Anopheles sinensis 300 230 585 1115 (7.6) Armigeres obturbans 150 0 46 196 (1.3) Culex pipiens pallens 0 0 56 56 (0.4) Culex tritaeniorhynchus 3675 5850 3170 12695 (86.2) Mansonia uniformis 0 0 29 29 (0.2) Total 4155 6650 3914 14719 (100.0)www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4908 | DOI: 10.1038/srep04908 2",Non-OADS,/arxiv_data1/oa_pdf/04/63/srep04908.PMC4014896.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4908 | DOI: 10.1038/srep04908 7",Non-OADS,/arxiv_data1/oa_pdf/04/63/srep04908.PMC4014896.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/23/32/srep04739.PMC4014979.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4739 | DOI: 10.1038/srep04739 7",Non-OADS,/arxiv_data1/oa_pdf/23/32/srep04739.PMC4014979.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7b/19/srep04850.PMC4014980.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4850 | DOI: 10.1038/srep04850 5",Non-OADS,/arxiv_data1/oa_pdf/7b/19/srep04850.PMC4014980.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4903 | DOI: 10.1038/srep04903 6",Non-OADS,/arxiv_data1/oa_pdf/a7/f1/srep04903.PMC4014981.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4902 | DOI: 10.1038/srep04902 7",Non-OADS,/arxiv_data1/oa_pdf/ec/5c/srep04902.PMC4014982.pdf
The quantitative analyses of fluorescence intensities were carried out with CpAtlas 2.0 software http://lazarsoftware.com) by quantifying pixels related to the area ofberberine spots in the green color channel.,OADS,/arxiv_data1/oa_pdf/f1/2a/srep04914.PMC4014983.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f1/2a/srep04914.PMC4014983.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4914 | DOI: 10.1038/srep04914 12",Non-OADS,/arxiv_data1/oa_pdf/f1/2a/srep04914.PMC4014983.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/28/f2/srep04896.PMC4014985.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4896 | DOI: 10.1038/srep04896 11",Non-OADS,/arxiv_data1/oa_pdf/28/f2/srep04896.PMC4014985.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4899 | DOI: 10.1038/srep04899 6",Non-OADS,/arxiv_data1/oa_pdf/23/9e/srep04899.PMC4014988.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4911 | DOI: 10.1038/srep04911 6",Non-OADS,/arxiv_data1/oa_pdf/8d/34/srep04911.PMC4015027.pdf
"We also acknowledge the contribution of Australian Ovarian Cancer Study Group (full list can be found at http://www.aocstudy.org), all study nurses and research assistants and would like to thank all of the women who participated in AOCS.",Non-OADS,/arxiv_data1/oa_pdf/20/31/srep04669.PMC4015028.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/31/srep04669.PMC4015028.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4669 | DOI: 10.1038/srep04669 8",Non-OADS,/arxiv_data1/oa_pdf/20/31/srep04669.PMC4015028.pdf
"The trial recruited 1050 women  This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs  licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution  of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/df/ntu029.PMC4015104.pdf
"TC, SC, SL, LV , and KB  are members of the UK Center for Tobacco and Alcohol Studies  (http://www.ukctas.ac.uk).",Non-OADS,/arxiv_data1/oa_pdf/52/df/ntu029.PMC4015104.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/eb/df/srep04752.PMC4015134.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4752 | DOI: 10.1038/srep04752 8",Non-OADS,/arxiv_data1/oa_pdf/eb/df/srep04752.PMC4015134.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/8b/2d/JISPCD-4-1.PMC4015153.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/8b/2d/JISPCD-4-1.PMC4015153.pdf
Available from: http://www.who.int/whr/2006/whr06_ en.pdf.,OADS,/arxiv_data1/oa_pdf/84/c3/JISPCD-4-17.PMC4015155.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/84/c3/JISPCD-4-17.PMC4015155.pdf
"Available from: http://www.ruidp.rajasthan.gov.in/ Water%20 Supply%20Sub‑project,%20Bharatpur%20pdf.",Non-OADS,/arxiv_data1/oa_pdf/71/79/JISPCD-4-52.PMC4015163.pdf
The application can be downloaded from http://itunes.apple.com/us/app/ medknow‑journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/07/2b/JISPCD-4-56.PMC4015164.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.280 280Importance of Rectal Urgency in Childhood  Irritable Bowel Syndrome TO THE EDITOR:  We read with interest the article titled “The  incidence of irritable bowel syndrome in children using the Rome  III criteria and the effect of trimebutine treatment” by Karabulut et al 1 that is a rare and a valuable study from our country.",Non-OADS,/arxiv_data1/oa_pdf/72/e0/jnm-20-280.PMC4015190.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.212 Association Between Gastroesophageal Reflux  Disease After Pneumatic Balloon Dilatation  and Clinical Course in Patients With Achalasia Yang Won Min, Jin Hee Lee, Byung-Hoon Min, Jun Haeng Lee, Jae J Kim and Poong-Lyul Rhee * Department of Medicine, Samsung Medical Center, Sungkyunkwan Un iversity School of Medicine, Seoul, Korea  Background/Aims The occurrence of gastroesophageal reflux disease (GERD) is known to be associated with lower post-treatment lower esoph- ageal sphincter pressure in patients with achalasia.",Non-OADS,/arxiv_data1/oa_pdf/b2/40/jnm-20-212.PMC4015191.pdf
"ORCID: Yang Won Min, http://orcid.org/0000-0001-7471-1305; Jae J Kim, http://orcid.org/0000-0002-0226-1330.",Non-OADS,/arxiv_data1/oa_pdf/b2/40/jnm-20-212.PMC4015191.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.171 Responses to Enteric Motor Neurons in the  Gastric Fundus of Mice With Reduced  Intramuscular Interstitial Cells of Cajal Kenton M Sanders, Anna K Salter, Grant W Hennig, Sang D on Koh, Brian A Perrino, Sean M Ward and Salah A Baker * Department of Physiology and Cell Biology, University of Nevada  School of Medicine, Reno, NV, USA Background/Aims Interstitial cells of Cajal (ICC) play important functions in motor activity of the gastrointestinal tract.",Non-OADS,/arxiv_data1/oa_pdf/72/7e/jnm-20-171.PMC4015192.pdf
"ORCID: Salah A Baker, http://orcid.org/0000-0002-1514-6876.",Non-OADS,/arxiv_data1/oa_pdf/72/7e/jnm-20-171.PMC4015192.pdf
"Supplementary Materials Note: To access the supplementary tables mentioned in this  article, visit the online version of Journal of Neurogastroenterol-ogy and Motility at http://www.jnmjournal.org/, and at doi:  http://dx.doi.org/10.5056/jnm.2014.20.2.171.",Non-OADS,/arxiv_data1/oa_pdf/72/7e/jnm-20-171.PMC4015192.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.236 236Received: November 15, 2013 Revised: December 27, 2013 Accepted: January 8, 2014 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/0c/91/jnm-20-236.PMC4015193.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.273 273Upregulation of Na v1.7 Through High Salt  Loading (Mol Pain 2013;9:39) Lian Zhu,1 Jung Hwan Oh2 and Yaohui Zhu3* 1Division of Pediatrics, Xiaogan Women and Children ’s Health Institute, Xiaogan, Hubei, China; 2Division of Gastroenterology, Department of  Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea; and 3Division of Gastroenterology, School of Medicine  Johns Hopkins University, Baltimore, MD, USA Received: November 14, 2013 Revised: February 16, 2014 Accepted: February 23, 2014 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/17/ce/jnm-20-273.PMC4015194.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.228 Unclear Abdominal Discomfort: Pivotal Role of  Carbohydrate Malabsorption Miriam Goebel-Stengel,1* Andreas Stengel,2 Marco Schmidtmann,1 Ivo van der Voort,1 Peter Kobelt2 and Hubert Mönnikes1 1Department of Internal Medicine, Institute of Neurogastroentero logy and Motility, Martin-Luther Hospital, Academic Teaching In stitution of  Charité - University Medical Center, Berlin, Germany;  and  2Charité Center for Internal Medicine and Dermatology, Division of Gene ral Internal  and Psychosomatic Medicine; Charit é-Universit ätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany Background/Aims Carbohydrate malabsorption is frequent in patients with functional gastrointestinal disorders and in healthy volunteers and can   cause gastrointestinal symptoms mimicking irritable bowel syndrome (IBS).",Non-OADS,/arxiv_data1/oa_pdf/9f/85/jnm-20-228.PMC4015196.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.278 278A New Approach Is Needed to Analyze the  Upper Esophageal Sphincter Because  Currently Incorporated High-resolution Manometry Analysis Software Package Is Not  Perfect Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/07/17/jnm-20-278.PMC4015197.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.253 Fate of Dyspeptic or Colonic Symptoms After  Laparoscopic Cholecystectomy Gi Hyun Kim,1 Hyo Deok Lee,1 Min Kim,1 Kyeongmin Kim,1 Yusook Jeong,1 Yong Joo Hong,1 Eun Seok Kang,1 Joung-Ho Han,1  Jae-Woon Choi2 and Seon Mee Park1* Departments of 1Internal Medicine and 2Surgery, Chungbuk National University College of Medicine, Cheo ngju, Chungcheongbuk-do, Korea Background/Aims Gallbladder diseases can give ri se to dyspeptic or colonic symptoms in additi on to biliary pain.",Non-OADS,/arxiv_data1/oa_pdf/1c/e8/jnm-20-253.PMC4015198.pdf
"ORCID: Seon Mee Park, http://orcid.org/0000-0002-5835-2741.",Non-OADS,/arxiv_data1/oa_pdf/1c/e8/jnm-20-253.PMC4015198.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.205 Impedance pH Monitoring: Intra-observer and  Inter-observer Agreement and Usefulness of a  Rapid Analysis of Symptom Reflux Association Andrea Tenca,1 Pietro Campagnola,2 Ivana Bravi,3 Luigi Benini,2 Daniel Sifrim3 and Roberto Penagini1* 1Gastroenterology Unit 2, Universit à degli Studi di Milano and Fondazione IRCCS “Ca’ Granda ” - Ospedale Maggiore Policlinico, Milan, Italy;  2Gastroenterology Unit, Universit à degli Studi di Verona and Policlinico GB Rossi, Verona, Italy; and 3Barts and The London School of Medicine  and Dentistry, Queen Mary University of London, London, UK Background/Aims Symptom reflux association analysis is especially helpful for evaluation and management of proton pump inhibitor (PPI) re- fractory patients.",Non-OADS,/arxiv_data1/oa_pdf/45/f5/jnm-20-205.PMC4015199.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.138 138The Usefulness of “ Analysis of Burden of  Irritable Bowel Syndrome From National  Health Insurance Claims Database” in the Healthcare Policy in Korea Kyoung Sup Hong Division of Gastroenter ology, Department of Internal Medicine, Seoul National University College of Medicine and Seoul Nationa l University  Hospital, Seoul, Korea Article :Estimating the burden of irritable bowel syndrome: analysis of a nationwide Korean database Jung HK, Kim YH, Park JY, et al.",OADS,/arxiv_data1/oa_pdf/52/1d/jnm-20-138.PMC4015200.pdf
"*Correspondence: Kyoung Sup Hong, MD  Division of Gastroenterology, Department of Internal Medicine, Seoul National University College of Medicine and Seoul Nationa l  University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, K orea Tel: +82-2-2072-0360, Fax: +82-2-762-9662, E-mail: ks hong1@empas.com Financial support: None.Conflicts of interest: None.ORCID: http://orcid.org/0000-0001-7087-1168.In Korea, all citizens are automatically registered for the com- pulsory insurance program, the National Health Insurance  (NHI) system.",Non-OADS,/arxiv_data1/oa_pdf/52/1d/jnm-20-138.PMC4015200.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.141 141Emerging Pharmacologic Therapies for  Constipation-predominant Irritable Bowel  Syndrome and Chronic Constipation Shanti Eswaran, Amanda Guentner and William D Chey * University of Michigan Healt h System, Ann Arbor, MI, USA Irritable bowel syndrome with constipation and chronic functional constipation are common digestive disorders that negatively  impact quality of life and account for billions  of dollars in health care  costs.",Non-OADS,/arxiv_data1/oa_pdf/8d/98/jnm-20-141.PMC4015201.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.219 Applying Novel Nutrient Drink to Clinical Trial  of Functional Dyspepsia Chul-Hyun Lim, Myung-Gyu Choi, * Myong Ki Baeg, Sung Jin Moon, Jin Su Ki m, Yu Kyung Cho, Jae Myung Park, In Seok  Lee, Sang Woo Kim and Kyu Yong Choi Department of Internal Medicine, The Catholic University of Kor ea College of Medicine, Seoul, Korea Background/Aims The drink test has been regarded as a surrogate marker of ga stric accommodation.",Non-OADS,/arxiv_data1/oa_pdf/ef/41/jnm-20-219.PMC4015202.pdf
"ORCID: Myung-Gyu Choi, http://orcid.org/0000-0003-4083-5187.",Non-OADS,/arxiv_data1/oa_pdf/ef/41/jnm-20-219.PMC4015202.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.152 The Efficacy of Hypnotherapy in the  Treatment of Irritable Bowel Syndrome:  A Systematic Review and Meta-analysis Han Hee Lee,1 Yoon Young Choi2 and Myung-Gyu Choi1* 1Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, K orea; and  2Department of Surgery, Yonsei University College of Medicine, S eoul, Korea Background/Aims Hypnotherapy is considered as a promising intervention for irritable bowel syndrome (IBS), but the evidence is still limited.",Non-OADS,/arxiv_data1/oa_pdf/21/27/jnm-20-152.PMC4015203.pdf
"ORCID: Han Hee Lee, http://orcid.org/0000-0002-8244-374X; Myung -Gyu Choi, http://orcid.org/0000-0003-4083-5187.",Non-OADS,/arxiv_data1/oa_pdf/21/27/jnm-20-152.PMC4015203.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.242 Estimating the Burden of Irritable Bowel  Syndrome: Analysis of a Nationwide Korean  Database Hye-Kyung Jung,1 Youn Hee Kim,2 Joo Yeon Park,2 Bo Hyoung Jang,2,3 Sun-Young Park,2,4 Mi-Hee Nam2 and Myung-Gyu Choi2,5* 1Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea;2National Evidence-based Healthcare Collaborating  Agency, Seoul, Korea;3College of Korean Medicine, Kyung Hee University, Seoul, Korea;4School of Pharmacy, Sungkyunkwan University,  Suwon, Gyeonggi-do, Korea; and5Department of Internal Medicine, College of Medicine, The Catho lic University of Korea, Seoul, Korea Background/Aims Management of irritable bowel syndrome (IBS) imposes a heavy economic burden.",Non-OADS,/arxiv_data1/oa_pdf/d5/75/jnm-20-242.PMC4015204.pdf
"ORCID: Hye-Kyung Jung, http://orcid.org/0000-0002-6653-5214; My ung-Gyu Choi, http://orcid.org/0000-0003-4083-5187.",Non-OADS,/arxiv_data1/oa_pdf/d5/75/jnm-20-242.PMC4015204.pdf
"Supplementary Materials Note: To access the supplementary tables mentioned in this  article, visit the online version of Journal of Neurogastroenter- ology and Motility at http://www.jnmjournal.org/, and at doi:  http://dx.doi.org/10.5056/jnm.2014.20.2.242.",Non-OADS,/arxiv_data1/oa_pdf/d5/75/jnm-20-242.PMC4015204.pdf
Available from URL: http://www.whocc.no/atc_  ddd_index (accessed 5 March 2014).,OADS,/arxiv_data1/oa_pdf/d5/75/jnm-20-242.PMC4015204.pdf
Available  from URL: http://www.whocc.no/atc_ddd_publications/guidelines  (accessed 5 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/d5/75/jnm-20-242.PMC4015204.pdf
Available from URL: http://apps.who.int/classifications/apps/icd/ icd10online (accessed 5 March 2014).,OADS,/arxiv_data1/oa_pdf/d5/75/jnm-20-242.PMC4015204.pdf
Available from URL:  http://health.costhelper.com/colonoscopy.html (accessed 5 March  2014).,Non-OADS,/arxiv_data1/oa_pdf/d5/75/jnm-20-242.PMC4015204.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.135 135Fructose Malabsorption in Patients With  Irritable Bowel Syndrome-like Symptoms:  What Is the Role in the Pathogenesis and Clinical Implication?",Non-OADS,/arxiv_data1/oa_pdf/47/b2/jnm-20-135.PMC4015205.pdf
"ORCID: Yong Sung Kim, http://orcid.org/0000-0001-8836-4818.Abdominal discomfort with negative medical tests is a com- mon presentation in the gastrointestinal (GI) clinic, and it is usu-ally diagnosed as irritable bowel syndrome (IBS).",Non-OADS,/arxiv_data1/oa_pdf/47/b2/jnm-20-135.PMC4015205.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.261 261A Pilot Trial of Ambulatory Monitoring of  Gastric Motility Using a Modified Magnetic  Capsule Endoscope Hee Man Kim,1* Ja Sung Choi2 and Jae Hee Cho3 1Division of Gastroenterology and Hepatology, Department of Inte rnal Medicine, Yonsei University Wonju College of Medicine, Won ju,  Gangwon-do, Korea;2Division of Gastroenterology, Department of Internal Medicine, Myongji Hospital, Goyang, Gyeonggi-do, Korea; and  3Division of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea The magnetic capsule endoscope has been modified to be fixed inside the stomach and to monitor the gastric motility.",Non-OADS,/arxiv_data1/oa_pdf/c7/fd/jnm-20-261.PMC4015206.pdf
"Supplementary Material Note: To access the supplementary video mentioned in this  article, visit the online version of Journal of Neurogastroenterolo- gy and Motility at http://www.jnmjournal.org/, and at doi: http://dx.doi.org/10.5056/jnm.2014.20.2.261.",Non-OADS,/arxiv_data1/oa_pdf/c7/fd/jnm-20-261.PMC4015206.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.163 Placebo Effect in Clinical Trial Design for  Irritable Bowel Syndrome Eric Shah and Mark Pimentel * GI Motility Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA Ongoing efforts to improve clinical trial design in irritable bowel syndrome have been hindered by high placebo response rates  and ineffective outcome measures.",Non-OADS,/arxiv_data1/oa_pdf/8d/69/jnm-20-163.PMC4015207.pdf
Available from URL: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/8d/69/jnm-20-163.PMC4015207.pdf
Available from  URL: http://www.fda.gov/downloads/Drugs/Guidances/UCM205269.,Non-OADS,/arxiv_data1/oa_pdf/8d/69/jnm-20-163.PMC4015207.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.271 271High-resolution Anorectal Manometry for  Autonomic Dysreflexia in a Patient With  Incomplete Cervical Spinal Cord Injury Tae Hee Lee,1 Su Jin Hong2 and Joon Seong Lee1* 1Institute for Digestive Research, Digestive Disease Center, Soo nchunhyang University Seoul Hospital, Seoul, Korea; and2Department of  Internal Medicine, Soonchunhyang University College of Medicine , Bucheon, Gyeonggi-do, Korea Received: March 3, 2014 Revised: March 10, 2014 Accepted: March 1 2, 2014 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/jnm-20-271.PMC4015208.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.276 276Peroral Endoscopic Myotomy Is Expanding Its  Indications (J Am Coll Surg 2013;217:598-605) Hee Man Kim Department of Internal Medicine, Yonsei University Wonju Colleg e of Medicine, Wonju, Gangwon-do, Korea Received: November 28, 2013 Revised: None Accepted: November 30, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/bf/be/jnm-20-276.PMC4015209.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.185 185Autonomic Nerve Regulation of Colonic  Peristalsis in Guinea Pigs Irena Gribovskaja-Rupp, Reji Babygirija, Toku Takahashi * and Kirk Ludwig Department of Surgery, Medical College of Wisconsin and Zablock i VA Medical Center, Milwaukee, WI, USA Background/Aims Colonic peristalsi s is mainly regulated via intrinsic neurons in guinea  pigs.",Non-OADS,/arxiv_data1/oa_pdf/d0/46/jnm-20-185.PMC4015210.pdf
"Supplementary Material Note: To access the supplementary videos mentioned in this  article, visit the online version of Journal of Neurogastroenter-ology and Motility at http://www.jnmjournal.org/, and at doi:  http://dx.doi.org/10.5056/jnm.2014.20.2.185.",Non-OADS,/arxiv_data1/oa_pdf/d0/46/jnm-20-185.PMC4015210.pdf
"2   April,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2014.20.2.197 Association Between Non-erosive Reflux  Disease and High Risk of Obstructive Sleep  Apnea in Korean Population Chan Ran You, Jung Hwan Oh, * Minji Seo, Hye Yeon Lee, Hyonsoo Joo, Sung Hoon Jung, Sang Haak Lee and Myung-Gyu Choi Department of Internal Medicine, The Catholic University of Kor ea, College of Medicine, Seoul, Korea  Background/Aims Obstructive sleep apnea is becoming more important in gastroesop hageal reflux disease (GERD) patients.",Non-OADS,/arxiv_data1/oa_pdf/93/8c/jnm-20-197.PMC4015211.pdf
"ORCID: Chan Ran You, http://orcid.org/0000-0001-9384-0700; Jung  Hwan Oh, http://orcid.org/0000-0002-9274-882X; Sung Hoon Jung,   http://orcid.org/0000-0003-0303-7434.",Non-OADS,/arxiv_data1/oa_pdf/93/8c/jnm-20-197.PMC4015211.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/05/73/mt201432a.PMC4015224.pdf
These data can be obtained free of charge from The Cambridge Crystallographic DataCentre via www.ccdc.cam.ac.uk/data_request/cif.Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/67/15/ncomms4715.PMC4015318.pdf
"Reprints and permissions information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Zang, H.-Y.",Non-OADS,/arxiv_data1/oa_pdf/67/15/ncomms4715.PMC4015318.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4715 8 NATURE COMMUNICATIONS | 5:3715 | DOI: 10.1038/ncomms4715 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/67/15/ncomms4715.PMC4015318.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/2a/57/ncomms4789.PMC4015322.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Aerts, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/2a/57/ncomms4789.PMC4015322.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ncomms4736.PMC4015324.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lee, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ncomms4736.PMC4015324.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4736 10 NATURE COMMUNICATIONS | 5:3736 | DOI: 10.1038/ncomms4736 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ncomms4736.PMC4015324.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c9/64/ncomms4680.PMC4015328.pdf
"Reprints and permission information is available online at http://www.npg.nature.com/ reprintsandpermissions/ How to cite this article : Stefanovic, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/c9/64/ncomms4680.PMC4015328.pdf
The genome sequence and its annotation are available along with a genome browser at http://www.camelinadb.ca.,OADS,/arxiv_data1/oa_pdf/55/5f/ncomms4706.PMC4015329.pdf
"Repeat annotation .Using the assembled C. sativa genome as input, a de novo repeat library was constructed by using RECON and RepeatScout within RepeatModeler (Version 1.05; http://www.repeatmasker.org/RepeatModeler.html).",OADS,/arxiv_data1/oa_pdf/55/5f/ncomms4706.PMC4015329.pdf
The ﬁnal consensus repeat library was used to mask the genome by RepeatMasker (Version 3.3.0; http://www.repeatmasker.org/RMDownload.html).,OADS,/arxiv_data1/oa_pdf/55/5f/ncomms4706.PMC4015329.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4706 10 NATURE COMMUNICATIONS | 5:3706 | DOI: 10.1038/ncomms4706 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/55/5f/ncomms4706.PMC4015329.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Kagale, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/55/5f/ncomms4706.PMC4015329.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4706 ARTICLE NATURE COMMUNICATIONS | 5:3706 | DOI: 10.1038/ncomms4706 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/55/5f/ncomms4706.PMC4015329.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/2a/da/ncomms4773.PMC4015330.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Bartell, S. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/2a/da/ncomms4773.PMC4015330.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4773 12 NATURE COMMUNICATIONS | 5:3773 | DOI: 10.1038/ncomms4773 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/2a/da/ncomms4773.PMC4015330.pdf
wrote the manuscript.Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/e0/99/ncomms4735.PMC4015331.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ohzono, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/e0/99/ncomms4735.PMC4015331.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/43/58/ncomms4718.PMC4015332.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article: Omichi, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/43/58/ncomms4718.PMC4015332.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c2/95/ncomms4675.PMC4015334.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Muller, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/c2/95/ncomms4675.PMC4015334.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4675 14 NATURE COMMUNICATIONS | 5:3675 | DOI: 10.1038/ncomms4675 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c2/95/ncomms4675.PMC4015334.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/05/d0/708.PMC4015486.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.238246.114.,Non-OADS,/arxiv_data1/oa_pdf/05/d0/708.PMC4015486.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.,Non-OADS,/arxiv_data1/oa_pdf/06/05/689.PMC4015487.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.3Corresponding author E-mail eisenman@fhcrc.org Article is online at http://www.genesdev.",Non-OADS,/arxiv_data1/oa_pdf/06/05/689.PMC4015487.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months afterthe full-issue publication date (see http://genesdev.cshlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/8a/b0/765.PMC4015488.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.14These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/8a/b0/765.PMC4015488.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.237404.114.,Non-OADS,/arxiv_data1/oa_pdf/8a/b0/765.PMC4015488.pdf
"We used theTargetScan algorithm (http://www.targetscan.org), which has been shown to have one of the highest specificities in preselecting putative target genes (Shirdel et al.",OADS,/arxiv_data1/oa_pdf/8a/b0/765.PMC4015488.pdf
"As a first approach, we took advantage of the publicly available information contained in the University of California at Santa Cruzgenome (UCSC) browser (http://genome.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/8a/b0/765.PMC4015488.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/38/6f/749.PMC4015489.pdf
9Corresponding authors E-mail gunter.meister@vkl.uni-regensburg.de E-mail inga.loedige@vkl.uni-regensburg.de Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/38/6f/749.PMC4015489.pdf
"Mice produce an enigmatic class of piRNAs, called pachytene piRNAs, which arise from unannotated /C2112014 Izumi and Tomari This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/42/e1/665.PMC4015490.pdf
[Keywords : 21U RNA; C. elegans ; piRNA] 1Corresponding author E-mail tomari@iam.u-tokyo.ac.jp Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.241323.114.,OADS,/arxiv_data1/oa_pdf/42/e1/665.PMC4015490.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.,Non-OADS,/arxiv_data1/oa_pdf/96/24/735.PMC4015491.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.1Corresponding author E-mail aguilo@us.es Article published online ahead of print.",Non-OADS,/arxiv_data1/oa_pdf/96/24/735.PMC4015491.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.234070.113.,Non-OADS,/arxiv_data1/oa_pdf/96/24/735.PMC4015491.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3e/d6/797.PMC4015493.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.4Corresponding author E-mail hannon@cshl.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.235622.113.",Non-OADS,/arxiv_data1/oa_pdf/3e/d6/797.PMC4015493.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.,Non-OADS,/arxiv_data1/oa_pdf/11/a8/723.PMC4015496.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.3Present address: Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.",Non-OADS,/arxiv_data1/oa_pdf/11/a8/723.PMC4015496.pdf
4Corresponding authors E-mail danny.reinberg@nyumc.org E-mail frecilla@correo.ifc.unam.mx Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/11/a8/723.PMC4015496.pdf
"Results CTCF is required for regulation of the p53/Wrap53 locus The human p53 gene is mutated in ;50% of tumors (National Cancer Institute Surveillance Epidemiology and End Results Program, http://seer.cancer.gov).",Non-OADS,/arxiv_data1/oa_pdf/11/a8/723.PMC4015496.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/37/idr-7-111.PMC4015718.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 111–116Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  111ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S6090 6gold mining areas in suriname: reservoirs   of malaria resistance?,Non-OADS,/arxiv_data1/oa_pdf/4d/37/idr-7-111.PMC4015718.pdf
Available from: http://www.paho.org/hq/index.,Non-OADS,/arxiv_data1/oa_pdf/4d/37/idr-7-111.PMC4015718.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/4d/37/idr-7-111.PMC4015718.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/37/idr-7-111.PMC4015718.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/a6/copd-9-453.PMC4015719.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 453–456International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  453O R I G I N A L  R E S E A R C H open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5858 4The relationship between early reversibility test  and maximal inspiratory pressure in patients   with airway obstruction Sevket Ozkaya1 Adem Dirican2 Sule Ozbay Kaya3 Rabia C Karanfil3 Merve G Bayrak4 Ozgür Bostancı5 Ferah Ece1 1Department of Pulmonary Medicine,   Faculty of Medicine, Bahcesehir  University, Istanbul, 2Department   of Pulmonary Medicine, 3Department   of Physical Therapy and Rehabilitation  Clinic, Samsun Medicalpark Hospital,   4Department of Pulmonary Medicine,   Samsun Chest Diseases and Thoracic  Surgery Hospital, 5Academy of Sports,   Ondokuzmayis University, Samsun,   T urkey Correspondence: Sevket Ozkaya   Samsun Medicalpark Hospital,  Department of Pulmonary Medicine,  Samsun, PO 55200, Turkey   Tel +90 532 474 13 09   Fax +90 362 311 40 50   Email ozkayasevket@yahoo.co mAbstract:  Maximal inspiratory pressure (MIP) is a marker for assessing the degree of  respiratory muscle dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/e8/a6/copd-9-453.PMC4015719.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e8/a6/copd-9-453.PMC4015719.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/a6/copd-9-453.PMC4015719.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/52/ndt-10-719.PMC4015794.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 719–722Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  719LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6307 5Tipepidine in adolescent patients with depression:  a 4 week, open-label, preliminary study Tsuyoshi Sasaki1,2 Kenji Hashimoto3 Masumi Tachibana1 Tsutomu Kurata1 Hiroshi Kimura2 Hideki Komatsu2 Masatomo Ishikawa2 Tadashi Hasegawa2 Akihiro Shiina1 Tasuku Hashimoto2 Nobuhisa Kanahara4 T etsuya Shiraishi2 Masaomi Iyo1–4 1Department of Child Psychiatry,   Chiba University Hospital,   2Department of Psychiatry, Chiba  University Graduate School of  Medicine, 3Division of Clinical  Neuroscience, Chiba University  Center for Forensic Mental Health,   4Division of Medical Treatment and  rehabilitation, Chiba University  Center for Forensic Mental Health,   Inohana, Chiba, Japan Correspondence: Tsuyoshi Sasaki   Department of Child Psychiatry, Chiba  University Hospital, Inohana 1-8-1, Chiba,  260-8670, Japan   Tel +81 43 226 2297   Fax +81 43 226 2297   email sasaki@faculty.chiba-u.j pDear editor Depression in children and adolescents is a common, recurrent, and debilitating condi - tion associated with increased psychosocial, and medical morbidity and mortality.1 The global prevalence of depression in children and adolescents is 1%–2% and  3%–8%, respectively.2 Depressive symptoms are also associated with significant func - tional impairment in school and the work place (often requiring legal interventions),1–5  and an increased risk for substance abuse and suicide.6–9 Clinical guidelines suggest  the use of two selective serotonin reuptake inhibitors (SSRI), namely fluoxetine and  escitalopram, both of which are effective with generally acceptable safety profiles in  the treatment of adolescent depression.10 Additionally, combination treatment with  an SSRI and psychotherapy, typically cognitive behavioral therapy (CBT), has shown  benefit in this cohort.10 However, caution is warranted since antidepressants therapy in  children and adolescents is associated with increased rates of suicidal ideation11–13 and  adverse effects, characterized by excessive emotional arousal or behavioral activation.14  These results highlight the need for new therapies in adolescent patients with depres - sion, particularly therapies with fewer side effects.",Non-OADS,/arxiv_data1/oa_pdf/dd/52/ndt-10-719.PMC4015794.pdf
Available from: http://clinicaltrials.gov/ ct2/show/NCT0183584 7.,Non-OADS,/arxiv_data1/oa_pdf/dd/52/ndt-10-719.PMC4015794.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/dd/52/ndt-10-719.PMC4015794.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/52/ndt-10-719.PMC4015794.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/54/ndt-10-703.PMC4015795.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 703–709Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  703OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6003 4generation of superoxide anion radicals   and platelet glutathione peroxidase activity   in patients with schizophrenia anna Dietrich-Muszalska anna Kwiatkowska Department of Biological Psychiatry  of the chair of experimental and  clinical Physiology, Medical University  of lodz, lodz, Poland correspondence: anna Dietrich- Muszalska   Department of Biological Psychiatry of  the chair of experimental and clinical  Physiology, Medical University of lodz,   6/8 Mazowiecka street, lodz  92-215,  Poland   email tzn_lodz@post.p lAbstract:  Blood platelets are considered to be a peripheral marker in schizophrenia and other  psychiatric disorders.",Non-OADS,/arxiv_data1/oa_pdf/cf/54/ndt-10-703.PMC4015795.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cf/54/ndt-10-703.PMC4015795.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/54/ndt-10-703.PMC4015795.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/63/opth-8-869.PMC4015796.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 869–874Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  869Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5678 3Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Ousler 3rd et al Running head recto: Blink patterns in dry eye DOI: http://dx.doi.org/10.2147/OPTH.S56783 Blink patterns and lid-contact times   in dry-eye and normal subjects george W Ousler 3rd1 Mark B abelson1,2 Patrick r Johnston1 John rodriguez1 Keith lane1 lisa M smith1 1Ora, andover, M a, Usa; 2Department  of Ophthalmology, harvard Medical  school, Boston, M a, UsaPurpose:  To classify blinks in dry eye and normal subjects into six subtypes, and to define the  blink rate and duration within each type of blink, as well as the total lid-contact time/minute.",Non-OADS,/arxiv_data1/oa_pdf/a0/63/opth-8-869.PMC4015796.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a0/63/opth-8-869.PMC4015796.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 874Ousler 3rd et al symptoms: the Ocular Surface Disease Index.30 Our study  provides a quantification of this blink anomaly by determining  actual mean lid-contact time per type of blink and the differ - ences noted between dry-eye and normal subjects.,Non-OADS,/arxiv_data1/oa_pdf/a0/63/opth-8-869.PMC4015796.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/87/ndt-10-711.PMC4015797.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 711–718Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  711OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6196 5Methods of suicide predict the risks and   method-switching of subsequent suicide   attempts: a community cohort study in Taiwan Yu-chi huang1 Ya-Wen Wu2 chih-Ken chen3 liang-Jen Wang4 1Department of Psychiatry, Kaohsiung  chang gung Memorial hospital and  chang gung University college  of Medicine, Kaohsiung, Taiwan;   2Department of Psychiatry, chang  gung Memorial hospital, Keelung,   Taiwan; 3Department of Psychiatry,   chang gung Memorial hospital,   Keelung and chang gung University  school of Medicine, Taoyuan, Taiwan;   4Department of child and adolescent  Psychiatry, Kaohsiung chang gung  Memorial hospital and chang gung  University college of Medicine,   Kaohsiung, Taiwan correspondence: liang-Jen Wang   Department of child and adolescent  Psychiatry, Kaohsiung chang gung  Memorial hospital 123, Ta-Pei road,  Niao-sung District, Kaohsiung   city 83301, Taiwan   Tel +886 7 731 7123 ext 6319   Fax +886 7 732 6817   email wangliangjen@gmail.co mObjective:  Suicide is a major public health concern.",Non-OADS,/arxiv_data1/oa_pdf/85/87/ndt-10-711.PMC4015797.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/85/87/ndt-10-711.PMC4015797.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/87/ndt-10-711.PMC4015797.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/49/btu028.PMC4016701.pdf
Availability and implementation: N GSANE is implemented in bash and publicly available under BSD (3-Clause) licence via GitHub at https://github.com/BauerLab/ngsane.,OADS,/arxiv_data1/oa_pdf/53/4f/btu036.PMC4016703.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/4f/btu036.PMC4016703.pdf
Availability and implementation: Cas-OFFinder free access at http://www.rgenome.net/cas-offinder.,OADS,/arxiv_data1/oa_pdf/d2/95/btu048.PMC4016707.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/95/btu048.PMC4016707.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/0e/btu053.PMC4016711.pdf
"An updateiteration carries out the following four steps: (i) MSA extensionwith PHLAWD according to the initial configuration file; (ii) generation of distinct randomized stepwise addition order parsi- mony starting trees with Parsimonator (unpublished; availableunder GNU GPL at https://github.com/stamatak/Parsimonator- 1.0.2), extending the set of trees from the previous iteration by the newly added taxa; (iii) ML optimization of the comprehen-sive parsimony starting trees that now include all new taxa with ExaML or RAxML-Light; and (iv) selection of a subset of these ML trees (based on their likelihood scores) that will be used asstarting points for the next iteration.",Non-OADS,/arxiv_data1/oa_pdf/23/0e/btu053.PMC4016711.pdf
"We are currently operating an instance of our framework as part of the iPlant collaborative (http://www.iplantcollaborative.org/) to maintain and make available perpetually updated trees for the Viridiplantae clade (using the rbcL,matK andatpB genes).",OADS,/arxiv_data1/oa_pdf/23/0e/btu053.PMC4016711.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"All summary statistics andanalyses were adjusted for the complex survey design ofDiet and health of grapefruit consumers Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"cEstimates represent 2-day average intakes.Diet and health of grapefruit consumers Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"6 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"Two-day average intake of food components from foods other than grapefruit by male and female grapefruit consumers and non- consumers aged 19 /C27years, NHANES 2003 /C12008 Males Females Grapefruit consumersa (n/C30153)Grapefruit non-consumers (n/C306,237)Grapefruit consumersa (n/C30180)Grapefruit non-consumers (n/C306,219) Food component Mean SE Mean SE P Mean SE Mean SE P T otal fruit (cup eq/day) 1.6 0.14 1.0 0.03 B0.001 1.3 0.08 1.0 0.03 B0.001 T otal vegetables (cup eq/day) 2.1 0.11 1.8 0.02 0.026 1.7 0.11 1.5 0.02 0.097 T otal grains (ounce eq/day) 7.4 0.36 7.8 0.07 0.210 5.2 0.23 5.6 0.05 0.138Whole grains (ounce eq/day) 1.3 0.26 0.8 0.03 0.031 0.9 0.12 0.7 0.03 0.039T otal dairy (cup eq/day) 1.6 0.11 1.7 0.04 0.101 1.3 0.09 1.4 0.03 0.357Meat/franks (ounce eq/day) 3.6 0.47 3.7 0.07 0.877 1.4 0.14 2.1 0.04 B0.001 Poultry (ounce eq/day) 1.2 0.15 1.7 0.05 0.003 1.5 0.16 1.3 0.04 0.097T otal fish (ounce eq/day) 1.1 0.26 0.7 0.04 0.158 0.9 0.20 0.5 0.03 0.080Eggs (ounce eq/day) 0.7 0.10 0.6 0.01 0.298 0.4 0.04 0.4 0.01 0.982 Nuts/seeds/soy/legumes (ounce eq/day)1.2 0.27 0.9 0.04 0.274 1.0 0.22 0.7 0.03 0.172 Discretionary oil (g/day) 23.5 1.94 21.3 0.39 0.237 15.4 1.45 16.6 0.22 0.414 Discretionary solid fat (g/day) 48.4 3.00 53.0 0.57 0.132 30.9 1.77 37.1 0.44 0.002Added sugars (teaspoon/day) 17.0 1.21 21.3 0.40 0.002 12.3 0.87 15.0 0.29 0.008 aGrapefruit consumers reported consumption of 100% grapefruit juice or 100% fresh, canned, or frozen grapefruit at least once on the 2 days of dietary recall.Diet and health of grapefruit consumers Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"8 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://www.ecfr.gov/cgi-bin/retrieveECFR?gp /C301&SID/C30c880ef379537b77746b24e59217513c0&ty /C30 HTML&h /C30L&r/C30APPENDIX&n /C3021y2.0.1.1.2.7 .1.4.3 [cited 26 March 2013].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://www.ars.usda.gov/Services/docs.htm?docid /C308964 [cited 26 March 2013].,Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"J Food Compost Anal 1999; 12:169/C196.Diet and health of grapefruit consumers Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"Beltsville, MD.http://www.ars.usda.gov/Services/docs.htm?docid /C306231 [cited 21 December 2011].",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://www.ars.usda.gov/SP2UserFiles/Place/12355000/pdf/Portion.pdf [cited 12 February 2012].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/nchs/ nhanes/search/datapage.aspx?Component /C30Dietary&CycleBegin Year/C302003 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/nchs/ nhanes/search/datapage.aspx?Component /C30Dietary&CycleBegin Year/C302005 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/nchs/ nhanes/search/datapage.aspx?Component /C30Dietary&CycleBegin Year/C302007 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://www.ars.usda.gov/Services/docs.htm?docid /C3020511 [cited 21 December 2011].,Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://www.ars.usda.gov/Services/docs.htm?docid /C3017031 [cited 21 December 2011].,Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://www.ars.usda.gov/Services/docs.htm?docid /C3012083 [cited 21 December 2011].,Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://www.ars.usda.gov/Services/ docs.htm?docid /C30 17563 [cited 21 December 2011].,Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/ nchs/nhanes/search/datapage.aspx?Component /C30Examination& CycleBeginYear /C302003 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/ nchs/nhanes/search/datapage.aspx?Component /C30Examination& CycleBeginYear /C302005 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/ nchs/nhanes/search/datapage.aspx?Component /C30Examination& CycleBeginYear /C302007 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/nchs/ nhanes/search/datapage.aspx?Component /C30Laboratory&Cycle BeginYear /C302003 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/nchs/ nhanes/search/datapage.aspx?Component /C30Laboratory&Cycle BeginYear /C302005 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/nchs/ nhanes/search/datapage.aspx?Component /C30Laboratory&Cycle BeginYear /C302007 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/ nchs/nhanes/search/datapage.aspx?Component /C30Demographics& CycleBeginYear /C302003 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/ nchs/nhanes/search/datapage.aspx?Component /C30Demographics& CycleBeginYear /C302005 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/ nchs/nhanes/search/datapage.aspx?Component /C30Demographics& CycleBeginYear /C302007 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/ nchs/nhanes/search/datapage.aspx?Component /C30Questionnaire& CycleBeginYear /C302003 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/ nchs/nhanes/search/datapage.aspx?Component /C30Questionnaire& CycleBeginYear /C302005 [cited 21 December 2011].Mary M. Murphy et al.,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"10 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://wwwn.cdc.gov/ nchs/nhanes/search/datapage.aspx?Component /C30Questionnaire& CycleBeginYear /C302007 [cited 21 December 2011].,OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
http://ndb.nal.,Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"*Mary M. Murphy Exponent †, Inc., Center for Chemical Regulation & Food Safety 1150 Connecticut Avenue, NW, Suite 1100Washington, DC 20036USA Email: mmurphy@exponent.comDiet and health of grapefruit consumers Citation: Food & Nutrition Research 2014, 58: 22179 - http://dx.doi.org/10.3402/fnr.v58.22179 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/57/2a/FNR-58-22179.PMC4016745.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-com mercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7d/b2/MEHD-25-24145.PMC4016746.pdf
"Details of biochemical events associated with epigenomic regulations of gene expression in eukaryotic and prokaryotic organisms haveBoris A. Shenderov and Tore Midtvedt 2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145",OADS,/arxiv_data1/oa_pdf/7d/b2/MEHD-25-24145.PMC4016746.pdf
"Main participants and potential inductors of host epigenomic alterations Main donors of target affect groups or substances S-Adenosyl methionine Methyl group Acetyl-CoA Acetyl groupNicotinamide adenine dinucleotide (NAD/C27)ADP ribosyl group Adenosine triphospate (ATP) Phosphate group Coenzyme Q UbiquinoneBiotin BiotinNucleotides, double- or single-stranded RNAmicroRNA Some enzymes involved in epigenomic machines DNA & RNA and histone methyltransferases; demethylases;acetyltransferases, deacetylases; ribosyltransferases, hydrolases; phosphotransferases, kinases; Bir A ligase; synthetases, nucleases, DNA & RNA-ligasesEpigenomic programing Citation: Microbial Ecology in Health & Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7d/b2/MEHD-25-24145.PMC4016746.pdf
"resveratrol, lycopene, a-lipoic acid)Boris A. Shenderov and Tore Midtvedt 4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145",Non-OADS,/arxiv_data1/oa_pdf/7d/b2/MEHD-25-24145.PMC4016746.pdf
"The most distributed deﬁciencies of essential minerals in the human diet The necessary amount of microelements (mg/daily)Number of people (billions) with microelement deficiencyMicroelements quantity (mg/kg) in the gut microbe biomass Zinc 30.0 4.5 499.6 954.4 Copper 2.0 3.6 /C13.8 46.9 94.4 Chrome 0.15 3 1.44 90.15 Iron 20.0 1 584.9 9120.2 Iodine 0.15 1 2.8 90.43 Selenium 0.1 1 1.73 /C270.17Epigenomic programing Citation: Microbial Ecology in Health & Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7d/b2/MEHD-25-24145.PMC4016746.pdf
"Moscow: DeLi Print; 2008, 319 p. (in Russian).Boris A. Shenderov and Tore Midtvedt 6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145",Non-OADS,/arxiv_data1/oa_pdf/7d/b2/MEHD-25-24145.PMC4016746.pdf
"J Physiol 2004; 558: 263 /C175.Epigenomic programing Citation: Microbial Ecology in Health & Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7d/b2/MEHD-25-24145.PMC4016746.pdf
"J Nutr 2010; 140: 671 /C18.Boris A. Shenderov and Tore Midtvedt 8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145",OADS,/arxiv_data1/oa_pdf/7d/b2/MEHD-25-24145.PMC4016746.pdf
"The API provides read and write capabilities, and is designed to be embedded in other soft- ware packages, enabling mzQuantML support to be added to proteomics software tools (http://code.google.com/p/jmzquantml/).",OADS,/arxiv_data1/oa_pdf/8c/b3/pmic0014-0685.PMC4016760.pdf
"In this article, we also describe a Java software tool (http://code.google.com/p/mzquantml-validator/) for validating mzQuantML ﬁles, which is a formal part of the data standard.",OADS,/arxiv_data1/oa_pdf/8c/b3/pmic0014-0685.PMC4016760.pdf
All the latest example ﬁles can be found in http://code.google .com/p/mzquantml/source/browse/#svn/trunk/examples/ version1.0.,OADS,/arxiv_data1/oa_pdf/8c/b3/pmic0014-0685.PMC4016760.pdf
The API is copyrighted under the Apache Software License 2.0 (http://www.apache.org/licenses/ LICENSE-2.0.html).,OADS,/arxiv_data1/oa_pdf/8c/b3/pmic0014-0685.PMC4016760.pdf
can be found in http://code.google.com/p/jmzquantml/).,OADS,/arxiv_data1/oa_pdf/8c/b3/pmic0014-0685.PMC4016760.pdf
A technique called the xxIndex (http://code.google.com/p/pride-toolsuite/wiki/XXIndex) is employed in jmzQuantML to allow random access to any XML element in an mzQuantML ﬁle via its XPath (the hierar- chy and location of an element within an XML ﬁle).,OADS,/arxiv_data1/oa_pdf/8c/b3/pmic0014-0685.PMC4016760.pdf
"Although mzQuantML version 1.0 has only been a PSI standard since March 2013, there are already several software packages supporting the format, which use jmzQuantML in- ternally, such as ProteoSuite (http://www.proteosuite.org/), x-Tracker (http://www.x-tracker.info/) and the Progenesis Post-Processor [9].",OADS,/arxiv_data1/oa_pdf/8c/b3/pmic0014-0685.PMC4016760.pdf
"SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS We thank the American Asthma Foundation (HJMcS, NFB, RMM), the Wellcome Trust (KAS, RMM), Asthma UK (HJMcS) and the MRC (ANJMcK) for funding support, and Kara Filbey, Yvonne Harcus and Elaine Robertsonfor production of parasite materials and assistance with the studies presented.",Non-OADS,/arxiv_data1/oa_pdf/52/2d/mi2013123a.PMC4016792.pdf
"In addition,  previous histological analyses of glutamate transporters  in ocular hypertensive eyes reported conflicting results;  some reported decreases in Gamma-ray Large Area Space Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> Received 28 September 2010 | Accepted 30 April 2014 | Published 2 May 2014© 2014 Molecular Vision 606Hyperbaric pressure and increased susceptibility to glutamate  toxicity in retinal ganglion cells in vitro Makoto Aihara, Yi-Ning Chen, Saiko Uchida, Mao Nakayama, Makoto Araie Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan Purpose:  To investigate the effect of hyperbaric pressure on purified retinal ganglion cells (RGCs) and the additive effect  of hyperbaric pressure on glutamate-induced RGC death.",Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
"Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> © 2014 Molecular Vision  607Telescope (GLAST) and GLT1 immunoreactivities in RGCs  and/or Muller cells [ 18,22], while others reported increases  [15,23].",Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
"Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> © 2014 Molecular Vision  608Next, to investigate the direct effects of pressure variation on  RGCs, the cells were alternately cultivated under 0 mmHg  and +60 or +30 mmHg with an 8-h cycle for 72 h, and the  survival rate was compared to that of RGCs cultivated under  constant +30 or +15 mmHg hyperbaric pressure, which is the  average pressure variation value.",Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> © 2014 Molecular Vision  609and the downstream primer was labeled with a red dye  (LightCycler Red 640; Roche) at the 5′ end.,Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
"Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> © 2014 Molecular Vision  610concentrations of glutamate, which were insufficient to elicit  glutamate-induced cell death at normal or +15 mmHg of  pressure.",Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
"Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> © 2014 Molecular Vision  611were 55.8±6.5%, 66.4±5.6%, and 75.2±7.7%, respectively  (p<0.05 and p<0.01, respectively; Dunnett’s test; Figure 3B).",Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
"Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> © 2014 Molecular Vision  612glutamate, or the expression of RGC glutamate transporters,  GLT1 or EAAC1.",Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> © 2014 Molecular Vision  613Our results from using specific antagonists for NMDA  or kainite receptors suggest that both receptors contribute to  glutamate-induced cell death under hyperbaric pressure.,Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> © 2014 Molecular Vision  6148.,Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
Molecular Vision  2014; 20:606-615 <http://www.molvis.org/molvis/v 20/606> © 2014 Molecular Vision  61535.,Non-OADS,/arxiv_data1/oa_pdf/bc/c2/mv-v20-606.PMC4016804.pdf
"We previously showed for the  first time that a marked increase in the expression of MCP-1 Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> Received 3 September 2013 | Accepted 30 April 2014 | Published 2 May 2014© 2014 Molecular Vision 616Retinal neuronal MCP-1 induced by AGEs stimulates TNF-α  expression in rat microglia via p38, ERK, and NF-κB pathways Ning Dong, Libin Chang, Bingsong Wang, Liqun Chu From the Department of Ophthalmology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’ s Republic of  China Purpose:  Retinal microglia can be activated by retinal neuronal monocyte chemoattractant protein-1 (MCP-1) and play a  pivotal role in early retinal degeneration.",Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
"Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  617was distributed mainly around retinal vessel walls, as well as  in the cell bodies and synapses of the retinal ganglion cells  (RGCs) in a rodent DR model after streptozotocin (STZ)  injection, and this expression was consistently upregulated  at 3 and 5 months [ 26].",Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
"Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  618stimulation, the cells were rinsed twice with PBS and fixed  for 15 min in 4% paraformaldehyde (PFA) at room tempera - ture.",Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  619A Transwell culture system was designed in which  retinal neurons and microglial cells shared the same medium  but had no direct cell–cell interaction.,Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
"Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  620Soluble TNF-α was detected in the unstimulated  medium (9.12±2.58 pg/ml); however, exposure to AGEs led  to upregulation of TNF-α release (729.63±33.76 pg/ml), and  exposure to AGEs accompanied by MCP-1 blocking peptide  (136.89±22.45 pg/ml) and CCR2 knockdown (177.56±28.13  pg/ml) led to downregulation of TNF-α release in the retinal  neuron–microglia Transwell culture system (Figure 2D).",Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
"Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  621of phospho-ERK, lending additional support to the fact that  retinal neuronal MCP-1 induced by AGEs increases phospho- ERK levels in the microglial cells.",Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
"Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  622pathways, but not JNK:  As shown in Figure 7A, retinal  neuronal MCP-1 mRNA was set to 100%, when the primary  cultured retinal neurons were cultured with culture medium  alone for 48 h and used as a control.",Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
"Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  623TNF-α release (646.53±61.19 pg/ml), and exposure to AGEs  accompanied by CCR2 knockdown (145.41±10.97 pg/ml) led  to downregulation of TNF-α release in the retinal neuron– microglia Transwell culture system (Figure 7D).",Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  624MCP-1/CCR2 pathway with CCR2 knockdown can greatly  inhibit the effect of retinal neurons on microglia activation.,Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  625and TNF-α by microglia [ 36].,Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
"Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  626Although JNK and p38 mediate transcriptional and  post-transcriptional responses to proinflammatory stimuli,  the phosphorylation of both molecules ultimately signals  different components.",Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  627ischemia and optic nerve crush.,Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
Molecular Vision  2014; 20:616-628 <http://www.molvis.org/molvis/v 20/616> © 2014 Molecular Vision  628induction and microglial activation.,Non-OADS,/arxiv_data1/oa_pdf/e5/91/mv-v20-616.PMC4016805.pdf
"HuR binding to the U-rich element  is involved in β-actin mRNA stability, and the binding stabi - lizes the half-life of β-actin mRNA [ 5,11].Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> Received 7 June 2013 | Accepted 30 April 2014 | Published 2 May 2014© 2014 Molecular Vision 593Downregulation of β-actin and its regulatory gene HuR affect cell  migration of human corneal fibroblasts R. Joseph,1 O.P.",Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  594Our previous studies on keratoconus stroma showed that  β-actin and HuR expression levels were downregulated at the  mRNA and protein expression levels compared to normal  stroma.,Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  595buffer and analyzed with SDS–polyacrylamide gel elec - trophoresis (SDS–PAGE) using 12% polyacrylamide gels  [13].,OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  596RESULTS Human antigen R knockdown leads to a decrease in β-actin  expression in stromal fibroblasts at transcriptional and trans - lational levels:  Our previous results showed downregulation  in the expression of β-actin  and HuR genes in keratoconus  corneal stroma relative to normal corneas [ 12].,Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  597 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
"Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  598F-actin staining with rhodamine-labeled phalloidin (red  fluorescence), following transfection with scrambled siRNA,  siGAPDH, siHuR, or siβ-actin, respectively.",Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  599 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
"Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  6004F) were counted using Image-J software, incorporating  multiple images and standard deviation analysis.",OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  601 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
"Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  602siRNA, or HuR siRNA, respectively.",Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  603fibroblasts derived from the keratocytes of normal human  corneas.,Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
"Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  604The actin cytoskeleton is indispensable for wound  repair, and PI3K is one of the key enzymes involved in this  process [ 33].",Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
Molecular Vision  2014; 20:593-605 <http://www.molvis.org/molvis/v 20/593> © 2014 Molecular Vision  60520.,Non-OADS,/arxiv_data1/oa_pdf/92/b2/mv-v20-593.PMC4016806.pdf
Copyright © 2014 Korean Neurological Association   101Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.101 ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):101-107 Introduction Hemispherectomy has been recognized as an effective treat - ment modality for refractory epilepsy in children with hemi - spheric epileptogenic lesions.,Non-OADS,/arxiv_data1/oa_pdf/7d/69/jcn-10-101.PMC4017012.pdf
"108   Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.108ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):108-118 Idiopathic Small Fiber Neuropathy: Phenotype, Etiologies,   and the Search for Fabry Disease  Kristin Samuelsson,a Konstantinos Kostulas,a Magnus Vrethem,b Arndt Rolfs,c Rayomand Pressa aDepartment of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Huddinge,   Stockholm, Sweden  bDivision of Neurology and Clinical Neurophysiology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences,  Linköping University, Linköping, Sweden  cAlbrecht-Kossel Institute for Neuroregeneration, University of Rostock, Rostock, Germany Received  September 20, 2013 Revised  October 25, 2013 Accepted  October 28, 2013 Correspondence Kristin Samuelsson, MDDepartment of Neurology R54, Karolinska University Hospital Huddinge, 141 86 Stockholm, SwedenTel    +46858587247 Fax   +4687744822E-mail    kristin.samuelsson@ki.seBackground and Purpose zzThe etiology of small fiber neuropathy (SFN) often remains un- clear.",Non-OADS,/arxiv_data1/oa_pdf/d0/7e/jcn-10-108.PMC4017013.pdf
   Copyright © 2014 Korean Neurological Association   119 Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.119 ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):119-124 Introduction About half of the patients with acetylcholine-receptor-antibody (AChR-Ab)-negative myasthenia gravis (MG) have antibodies  against muscle-specific tyrosine kinase (MuSK-Ab).,Non-OADS,/arxiv_data1/oa_pdf/12/6f/jcn-10-119.PMC4017014.pdf
"  Copyright © 2014 Korean Neurological Association  125Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.125ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):125-132 Introduction Obsessive-compulsive disorder (OCD ) is a prevalent psychi- atric disease that is characterized by disabling obsessions  about intrusive unwanted thoughts and images, and/or com-pulsions expressed as ritualized repetitive behaviors.",Non-OADS,/arxiv_data1/oa_pdf/be/07/jcn-10-125.PMC4017015.pdf
"  Copyright © 2014 Korean Neurological Association  133Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.133ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):133-139 Introduction  Vascular shear stress contributes to the site specificity of ath- erosclerotic lesions ; however, the utility of arterial shear stress  has been limited due to the technical difficulty of measuring this stress and uncertainty about the implications of the mech - anism for therapy.",Non-OADS,/arxiv_data1/oa_pdf/ca/9c/jcn-10-133.PMC4017016.pdf
"140   Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.140ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):140-147 Antioxidant Effects of Statins in Patients with Atherosclerotic  Cerebrovascular Disease Gyeong Joon Moon,a,b Suk Jae Kim,c Yeon Hee Cho,b Sookyung Ryoo,c Oh Young Bangc,d aMedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Korea  bClinical Research Center, Samsung Biomedical Research Institute, Seoul, Korea  cDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea  dSamsung Advanced Institute for Health Sciences and Technology, Seoul, Korea Received  March 30, 2013 Revised  November 8, 2013 Accepted  November 8, 2013 Correspondence Oh Young Bang, MD, PhDDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTel    +82-2-3410-3599 Fax   +82-2-3410-0052E-mail    nmboy@unitel.co.krBackground and Purpose zzOxidative stress is involved in the pathophysiological mecha- nisms of stroke (e.g., atherosclerosis ) and brain injury after ischemic stroke.",Non-OADS,/arxiv_data1/oa_pdf/00/43/jcn-10-140.PMC4017017.pdf
148  Copyright © 2014 Korean Neurological Association    Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.148ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):148-156 Introduction Multiple sclerosis (MS) is a chronic demyelinating disease of  the central nervous system that causes neurologic disability in young adults.,Non-OADS,/arxiv_data1/oa_pdf/30/55/jcn-10-148.PMC4017018.pdf
"Copyright © 2014 Korean Neurological Association  157Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.157ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):157-161 Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Korea:   Clinical Features, Treatment, and Outcome Jung-Ah Lim,a* Soon-Tae Lee,a* Keun-Hwa Jung,a Soyun Kim,a Jung-Won Shin,a   Jangsup Moon,a Jung-Ick Byun,a Tae-Joon Kim,a Yong-Won Shin,a Keon-Joo Lee,a   Young-Su Kim,b Kyung-Il Park,c Sang Kun Lee,a Kon Chua aDepartment of Neurology, Laboratory for Neurotherapeutics, Comprehensive Epilepsy Center, Biomedical Research Institute,   Seoul National University Hospital; Program in Neuroscience, Seoul National University College of Medicine, Seoul, Korea  bDepartment of Neurology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea  cDepartment of Neurology, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea Received  July 3, 2013 Revised  December 10, 2013 Accepted  December 12, 2013 Correspondence Kon Chu, MD, PhDDepartment of Neurology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, KoreaTel    +82-2-2072-1878 Fax   +82-2-3672-4949E-mail    stemcell.snu@gmail.com *  The first two authors contributed  equally to this work.Background and Purpose zzAnti-N-methyl-D-aspartate receptor (anti-NMDAR ) encephalitis  is the most common type of autoimmune synaptic encephalitis and it often responds to treat - ment.",Non-OADS,/arxiv_data1/oa_pdf/0a/fa/jcn-10-157.PMC4017019.pdf
"162  Copyright © 2014 Korean Neurological Association    Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.162 CASE REPORT J Clin Neurol 2014 ;10(2):162-165 Introduction Spontaneous eye movements are useful clinical signs in coma,  although they rarely have localizing value.1 The best-known  exception to this rule is ocular bobbing, which consists of rap - id downward conjugate movements of both eyes with a slower return to the baseline position, and is found in pontine lesions.",Non-OADS,/arxiv_data1/oa_pdf/cb/92/jcn-10-162.PMC4017020.pdf
"166  Copyright © 2014 Korean Neurological Association    Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.166CASE REPORT J Clin Neurol 2014 ;10(2):166-170 Introduction Inclusion-body myopathy (IBM) with Paget’s disease of the  bone (PDB) and frontotemporal dementia (FTD) (IBMPFD; Online Mendelian Inheritance in Man #167320) is a rare, late-onset autosomal dominant disorder arising from missense mu - tations in a gene on chromosome 9p21.1-p12 coding for valo - sin-containing protein (VCP).",Non-OADS,/arxiv_data1/oa_pdf/5c/9b/jcn-10-166.PMC4017021.pdf
"  Copyright © 2014 Korean Neurological Association    171Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.171CASE REPORT J Clin Neurol 2014 ;10(2):171-173 Introduction Spinal cord infarction is much less frequent than cerebral in - farction, accounting for only 1% of all strokes.1 The anterior  spinal artery supplies the anterior two-thirds of the spinal cord  via the sulcal (central) artery.",Non-OADS,/arxiv_data1/oa_pdf/dd/b2/jcn-10-171.PMC4017022.pdf
"Copyright © 2014 Korean Neurological Association   75Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.75REVIEW J Clin Neurol 2014 ;10(2):75-83 Introduction Stroke causes 9% of all deaths worldwide, second only to isch - emic heart disease.1,2 The prolonged disability experienced by  stroke survivors is even more devastating.",Non-OADS,/arxiv_data1/oa_pdf/56/76/jcn-10-75.PMC4017023.pdf
"84  Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.84ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):84-93 Analysis of Spatial and Temporal Protein Expression   in the Cerebral Cortex after Ischemia-Reperfusion Injury Yuan-Hao Chen,a Yung-Hsiao Chiang,b Hsin-I Maa aDepartment of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC   bSection of Neurosurgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan, ROC Received  April 3, 2013 Revised  September 24, 2013 Accepted  September 26, 2013 Correspondence Hsin-I Ma, MD, PhD Department of Neurological Surgery, Tri-Service General Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/92/28/jcn-10-84.PMC4017024.pdf
"94  Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.2.94ORIGINAL ARTICLE J Clin Neurol 2014 ;10(2):94-100 Prevalence of Anti-Ganglioside Antibodies and Their Clinical   Correlates with Guillain-Barré Syndrome in Korea :   A Nationwide Multicenter Study Jong Kuk Kim,a Jong Seok Bae,b Dae-Seong Kim,c Susumu Kusunoki,d Jong Eun Kim,e Ji Soo Kim,f   Young-Eun Park,c Ki-Jong Park,g Hyun Seok Song,h Sun Young Kim,i Jeong-Geun Lim,j Nam-Hee Kim,k   Bum Chun Suh,l Tai-Seung Nam,m Min Su Park,n Young-Chul Choi,o Eun Hee Sohn,p Sang-Jun Na,q   So Young Huh,r Ohyun Kwon,s Su-Yun Lee,a Sung-Hoon Lee,b Sun-Young Oh,t Seong-Hae Jeong,p   Tae-Kyeong Lee,u Dong Uk Kimv aDepartment of Neurology, College of Medicine, Dong-A University, Busan, Korea, bDepartment of Neurology, College of Medicine,   Hallym University, Seoul, Korea, cDepartment of Neurology, School of Medicine, Pusan National University, Busan, Korea,  dDepartment of Neurology, School of Medicine, Kinki University, Osaka, Japan, eDepartment of Industrial and Occupational Medicine,  Pusan National University School of Medicine, Busan, Korea, fDepartment of Neurology, College of Medicine, Seoul National University,  Seoul, Korea, gDepartment of Neurology, School of Medicine, Gyeongsang National University, Jinju, Korea, hDepartment of Neurology,  School of Medicine, Kyungpook National University, Daegu, Korea, iDepartment of Neurology, College of Medicine, University of Ulsan,  Ulsan, Korea, jDepartment of Neurology, School of Medicine, Keimyung University, Daegu, Korea, kDepartment of Neurology,   College of Medicine, Dongguk University, Seoul, Korea, lDepartment of Neurology, School of Medicine, Sungkyunkwan University, Seoul, Korea,   mDepartment of Neurology, Chonnam National University Medical School, Gwangju, Korea, nDepartment of Neurology,   School of Medicine, Yeungnam University, Daegu, Korea, oDepartment of Neurology, College of Medicine, Yonsei University, Seoul, Korea,  pDepartment of Neurology, School of Medicine, Chungnam National University, Daejeon, Korea, qDepartment of Neurology,   College of Medicine, Konyang University, Daejeon, Korea, rDepartment of Neurology, College of Medicine, Kosin University, Busan, Korea,  sDepartment of Neurology, School of Medicine, Eulji University, Seoul, Korea, tDepartment of Neurology, School of Medicine,   Chonbuk National University, Jeonju, Korea, uDepartment of Neurology, College of Medicine, Soonchunhyang University, Seoul, Korea,  vDepartment of Neurology, School of Medicine, Chosun University, Gwangju, Korea Received  July 20, 2013 Revised  October 5, 2013 Accepted  October 16, 2013 Correspondence Jong Seok Bae, MD, PhDDepartment of Neurology,  Kangdong Sacred Heart Hospital,  College of Medicine, Hallym University,  150 Seongan-ro, Gangdong-gu,  Seoul 134-701, KoreaTel    +82-2-2224-2854 Fax   +82-2-2224-2114E-mail    jsb_res@hotmail.co.krBackground and Purpose zzNo previous studies have investigated the relationship between  various anti-ganglioside antibodies and the clinical characteristics of Guillain-Barré syndrome  (GBS ) in Korea.",Non-OADS,/arxiv_data1/oa_pdf/93/f8/jcn-10-94.PMC4017025.pdf
"Despite the presence of clinical features of acute motor axonal neuropathy (AMAN ), 68% of anti-GM1- or  anti-GD1a-antibody-positive cases of GBS were diagnosed with acute inflammatory demyelin-ating polyradiculoneuropathy (AIDP ) by a single electrophysiological study.Open Access cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/f8/jcn-10-94.PMC4017025.pdf
"To view a copy of   this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/98/cd/psp20149a.PMC4017092.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4917 | DOI: 10.1038/srep04917 6",Non-OADS,/arxiv_data1/oa_pdf/92/16/srep04917.PMC4017211.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Lg(R) Channel distance(km)0 Figure 2 |Simulation: Secure-key rate Lg(R) vs channel distance L (km) from Bob to Alice.",Non-OADS,/arxiv_data1/oa_pdf/0f/12/srep04936.PMC4017212.pdf
"David R. Lide, ed., CRC Handbook of Chemistry and Physics, Internet Version 2005.,http://www.hbcpnetbase.com ., (CRC Press, 2005) Date of access: 09/01/ 2014.",OADS,/arxiv_data1/oa_pdf/24/49/srep04922.PMC4017213.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/24/49/srep04922.PMC4017213.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4922 | DOI: 10.1038/srep04922 9",Non-OADS,/arxiv_data1/oa_pdf/24/49/srep04922.PMC4017213.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4932 | DOI: 10.1038/srep04932 4",Non-OADS,/arxiv_data1/oa_pdf/0e/2d/srep04932.PMC4017214.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4920 | DOI: 10.1038/srep04920 8",Non-OADS,/arxiv_data1/oa_pdf/c1/4e/srep04920.PMC4017215.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4925 | DOI: 10.1038/srep04925 12",Non-OADS,/arxiv_data1/oa_pdf/6e/04/srep04925.PMC4017217.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4930 | DOI: 10.1038/srep04930 6",Non-OADS,/arxiv_data1/oa_pdf/d1/9c/srep04930.PMC4017219.pdf
J Clin Endocrinol Metab 2006; 91:4501–4 http://www.ncbi.nlm.nih.gov/pubmed/16895957.,Non-OADS,/arxiv_data1/oa_pdf/fe/36/rju030.PMC4017231.pdf
http://wokinfo.com/essays/impact-factor/ (2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/bb/srep04880.PMC4017244.pdf
http://thomsonreuters.com/ (2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/bb/srep04880.PMC4017244.pdf
http://wokinfo.com/ (2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/bb/srep04880.PMC4017244.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4c/bb/srep04880.PMC4017244.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4880 | DOI: 10.1038/srep04880 7",Non-OADS,/arxiv_data1/oa_pdf/4c/bb/srep04880.PMC4017244.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4924 | DOI: 10.1038/srep04924 10",Non-OADS,/arxiv_data1/oa_pdf/07/d8/srep04924.PMC4017245.pdf
Both SNVs have been described in the dbSNP database (http://www.ncbi.nlm.nih.gov/ projects/SNP/).,OADS,/arxiv_data1/oa_pdf/8e/d3/leu2013315a.PMC4017253.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ What does MRD in leukemia really mean?",Non-OADS,/arxiv_data1/oa_pdf/8e/d3/leu2013315a.PMC4017253.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Cyclophosphamide as a ﬁrst-line therapy in LGL leukemia Leukemia (2014) 28,1134–1136; doi:10.1038/leu.2013.359 Large granular lymphocyte (LGL) leukemia is a T or NK clonal disorder characterized by the tissue invasion of marrow, spleen and liver.",Non-OADS,/arxiv_data1/oa_pdf/e8/62/leu2013359a.PMC4017255.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G 4A Leukemia (2014) 28,1136–1138; doi:10.1038/leu.2013.363 A single-nucleotide polymorphism (SNP) in PAX5 leading to an amino-acid change in the octapeptide domain at positionc.547G 4A (p.Gly183Ser) has recently been described to conferan inherited susceptibility for childhood pre B-ALL.1This susceptibility was transmitted autosomal dominant intwo independent families with variable penetrance andaberrations of chromosomal part 9p resulting in loss of the wild-type (wt) PAX5 allele occurruring simultaneously in the leukemic cells.",Non-OADS,/arxiv_data1/oa_pdf/e8/62/leu2013359a.PMC4017255.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Outcomes in LEN-treated MDS patients with del(5q) AF List et al 1040 Leukemia (2014) 1033 – 1040 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/89/9d/leu2013305a.PMC4017258.pdf
"Gene set enrichment analysis24was performed in public mouse or human AML data sets.25,26The mRNA-seq data are available in the Sequence Read Archive database (https://www.ncbi.nlm.nih.gov/sra?term= SRA062239)under accession number SRA062239.",OADS,/arxiv_data1/oa_pdf/21/21/leu2013304a.PMC4017259.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Reprogramming of leukemia cells Y Liu et al 1080 Leukemia (2014) 1071 – 1080 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/21/21/leu2013304a.PMC4017259.pdf
"ACKNOWLEDGEMENTS Fondazione Cassa di Risparmio di Carpi (http://www.fondazionecrcarpi.it/), Associa- zione Italiana per la Ricerca sul Cancro (AIRC, Milano, http://www.airc.it/english/Table 5.",Non-OADS,/arxiv_data1/oa_pdf/b8/8d/leu2013302a.PMC4017260.pdf
"obiettivi-risultati-english.asp), project number 10005 ‘Special Program Molecular Clinical Oncology 5 /C21000’ to AGIMM (AIRC-Gruppo Italiano Malattie Mieloprolifera- tive, http://www.progettoagimm.it), AIRC project number 12055, Italian Ministry ofUniversity & Research (FIRB Project 2011, project number RBAP11CZLK_002 and PRIN2010–11, project number 2010NYKNS7, http://www.istruzione.it/web/ricerca) andProject Tecnopolo (Regione Emilia Romagna http://www.aster.it/tiki-index.php?pa-ge=TecnopoloMo), AIL Modena ONLUS (http://www.ailmodena.org/).",Non-OADS,/arxiv_data1/oa_pdf/b8/8d/leu2013302a.PMC4017260.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Targeted cancer exome sequencing of MPN E Tenedini et al 1059 &2014 Macmillan Publishers Limited Leukemia (2014) 1052 – 1059",Non-OADS,/arxiv_data1/oa_pdf/b8/8d/leu2013302a.PMC4017260.pdf
"The data were processed in the R platform using the Limma package.22,23The resulting log2-transformed ratios were as follows: Mi(gene x) ¼Log2[Cy5(polysomal-associated mRNA)/Cy3(non-polyso- mal mRNA)]; ( i/C0replicates of experiment, i¼1:3) The log2-transformed ratios of polysomal over subpolysomal signal for each condition were then analysed by a non-parametric ranking approach using the RankProd package.24,25mRNAs were clustered using Gene Ontology annotations through DAVID (david.abcc.ncifcrf.gov) and IPA(Ingenuity Systems, www.ingenuity.com); pie charts were created inMicrosoft Excel and heatmaps were created using MultiExperimentViewer MeV (http://www.tm4.org/mev.html).",OADS,/arxiv_data1/oa_pdf/4e/28/leu2013295a.PMC4017261.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Dysregulation of translation in DLBCL E Horvilleur et al 1102 Leukemia (2014) 1092 – 1102 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/4e/28/leu2013295a.PMC4017261.pdf
"For Permissions, please email: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/84/df/bbs072.PMC4017328.pdf
Available from: http://www.njrcentre.org.uk/ NjrCentre/Portals/0/Documents/NJR%208th %20Annual%20Report%202011.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/6c/26/or-2014-1-5247.PMC4017333.pdf
Available from: http://nrlweb.ihelse.,Non-OADS,/arxiv_data1/oa_pdf/6c/26/or-2014-1-5247.PMC4017333.pdf
Available from: https://aoanjrr.dmac.,Non-OADS,/arxiv_data1/oa_pdf/6c/26/or-2014-1-5247.PMC4017333.pdf
Available from: https://secure.cihi.ca/free_products/2008_cj rr_annual_report_en.pdf 28.,OADS,/arxiv_data1/oa_pdf/6c/26/or-2014-1-5247.PMC4017333.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercialreproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/ce/jit804.PMC4017359.pdf
Available at: http://www.who.int/entity/immuni zation/sage/SAGE_non-speci ﬁc_effects_vaccines_WG_jan_2013.pdf .,OADS,/arxiv_data1/oa_pdf/2c/ce/jit804.PMC4017359.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034",OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
"Assessment of LMPs haematotoxicity Six-week-old C57BL/6 mice received single intravenousinjections of 25 or 75 mg/kg of LMPs (approximately 10 and 30 times the IC50, respectively) or control vehiclesT cell microparticles suppress tumour Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034",OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
"*P B0.05, **P B0.01, ***P B0.001 vs. CTL.T cell microparticles suppress tumour Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034",OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
"*PB0.05, **P B0.01 vs. CTL.T cell microparticles suppress tumour Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034",OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
"Lung cancer proliferation correlates with [F-T cell microparticles suppress tumour Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23034 - http://dx.doi.org/10.3402/jev.v3.23034",OADS,/arxiv_data1/oa_pdf/2c/1f/JEV-3-23034.PMC4017619.pdf
18. http://www.amfar.org/abouthiv/article.aspx?id=3592 19. http://www.unaids.org/documents/20101123_FS_mena_ em_en.pdf Middle East Journal of Digestive Diseases/V ol 4/ No.1/ January 2012Taslimi et al.,Non-OADS,/arxiv_data1/oa_pdf/33/2d/mejdd-4-55.PMC4017692.pdf
Available from: http://www.iranica.,Non-OADS,/arxiv_data1/oa_pdf/70/69/mejdd-4-60.PMC4017697.pdf
History of Iranian Academies [in Persian] Available from:  uRL:http://www.persianacademy.ir/fa/History.aspx.,Non-OADS,/arxiv_data1/oa_pdf/70/69/mejdd-4-60.PMC4017697.pdf
REFERENCES 1. http://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/8c/8c/mejdd-4-28.PMC4017701.pdf
Available from: http://sinais.salud.gob.mx/descargas/xls/Princip_CausasMM_2005-2007.xls 2007.,Non-OADS,/arxiv_data1/oa_pdf/ed/1e/HIP-33-191.PMC4017755.pdf
https://openknowledge.worldbank.org/handle/10986/5976 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/70/80/MHN-35-337.PMC4017761.pdf
Sim-ilarity searches using BLAST were performed on the NCBI server (http://www.ncbi.nlm.nih.gov) and,OADS,/arxiv_data1/oa_pdf/aa/0b/BAB-31-335.PMC4017763.pdf
"Management ofpemphigus Benjamin S.Daniel1,2andDedee F.Murrell1,3* Addresses:1Faculty ofMedicine, University ofNew South Wales, High Street, Kensington, 2052, Sydney, Australia;2Skin andCancer Foundation Victoria, Drummond Street, Carlton 3053, Melbourne, Victoria, Australia;3Department ofDermatology, St.George Hospital, Gray Street, Kogarah 2217, Sydney, Australia *Corresponding author: Dedee F.Murrell (d.murrell@unsw.edu.au) F1000Prime Reports 2014, 6:32(doi:10.12703/P6-32) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/06/medrep-06-32.PMC4017903.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/32 Abstract Pemphigus isanautoimmune blistering disease characterized bycutaneous andmucosal blisters and erosions.,Non-OADS,/arxiv_data1/oa_pdf/1c/06/medrep-06-32.PMC4017903.pdf
"It is typically not Page 2 of 4 (page number not for citation purposes)F1000Prime Reports 2014, 6:32 http://f1000.com/prime/reports/m/6/32",Non-OADS,/arxiv_data1/oa_pdf/1c/06/medrep-06-32.PMC4017903.pdf
"Page 3 of 4 (page number not for citation purposes)F1000Prime Reports 2014, 6:32 http://f1000.com/prime/reports/m/6/32",Non-OADS,/arxiv_data1/oa_pdf/1c/06/medrep-06-32.PMC4017903.pdf
"Page 4 of 4 (page number not for citation purposes)F1000Prime Reports 2014, 6:32 http://f1000.com/prime/reports/m/6/32",Non-OADS,/arxiv_data1/oa_pdf/1c/06/medrep-06-32.PMC4017903.pdf
"Advances inthetreatment ofrheumatoid arthritis Nancy Vivar andRonald F.Van Vollenhoven* Address: Department ofMedicine, Unit ofClinical Therapy Research inInflammatory Diseases (ClinTRID), Karolinska University Hospital, D2:00, 171 76Stockholm, Sweden *Corresponding author: Ronald F.Van Vollenhoven (Ronald.van.Vollenhoven@ki.se) F1000Prime Reports 2014, 6:31(doi:10.12703/P6-31) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/31 Abstract Theintense pursuit ofnovel therapies inrheumatoid arthritis hasprovided physicians with anassorted set ofbiologic drugs totreat patients with moderate tosevere disease activity.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
"Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:31 http://f1000.com/prime/reports/m/6/31",Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
"Both treatment options showed comparable eff icacy and safety in patients Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:31 http://f1000.com/prime/reports/m/6/31",Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
"The ORAL Standard trial, a phase3 study, compared the efficacy and safety of tofacitinib andof the anti-TNF agent adalimumab to placebo, showing similar efficacy for the active compounds versus placebo, Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:31 http://f1000.com/prime/reports/m/6/31",Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
"At this time, we are participating Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:31 http://f1000.com/prime/reports/m/6/31",Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
"Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT: The PREMIER study: A multicenter, randomized, double-blind clinical trialof combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:31 http://f1000.com/prime/reports/m/6/31",Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
"Genovese MC, McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, Woodworth T, Gomez-Reino JJ: Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheuma- toid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:31 http://f1000.com/prime/reports/m/6/31",Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
"Emery P,Gottenberg JE,Rubbert-Roth A,Sarzi-Puttini P, Choquette D,Martínez Taboada VM, Barile-Fabris L,Moots RJ, Ostor A,Andrianakos A,Gemmen E,Mpofu C,Chung C,Gylvin LH, Finckh A:Rituximab versus analternative TNF inhibitor in patients with rheumatoid arthritis who failed torespond toa single previous TNF inhibitor: SWITCH-RA, aglobal, Page 8of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:31 http://f1000.com/prime/reports/m/6/31",Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:31 http://f1000.com/prime/reports/m/6/31",Non-OADS,/arxiv_data1/oa_pdf/14/c2/medrep-06-31.PMC4017904.pdf
"Advances inthemanagement ofmacular degeneration Michael Singer Address: Medical Center Ophthalmology Associates, SanAntonio, Texas, USA Email: msinger1@earthlink.net F1000Prime Reports 2014, 6:29(doi:10.12703/P6-29) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
"The electronic version ofthisarticle isthecomplete one andcanbefound at:http://f1000.com/prime/reports/m/6/29 Abstract Current management ofage-related macular degeneration (AMD) canbedivided into two categories: first, anti-vasoendothelial growth factor (anti-VEGF) injection forwet macular degeneration; second, anti-oxidant vitamins fordrymacular degeneration.",Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
"Page 2 of 5 (page number not for citation purposes)F1000Prime Reports 2014, 6:29 http://f1000.com/prime/reports/m/6/29",Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
"Thephase 1 study hasbeen completed inpatients with advanced Page 3of5 (page number notforcitation purposes)F1000Prime Reports 2014, 6:29 http://f1000.com/prime/reports/m/6/29",Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
"Future directions In the future, the goal in wet macular degeneration will be to completely arrest the disease viaa sustained delivery Page 4 of 5 (page number not for citation purposes)F1000Prime Reports 2014, 6:29 http://f1000.com/prime/reports/m/6/29",Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
[http://www.amdalliance.org/] 2.,Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
[http://www.ohrpharmaceutical.com]11.,Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
"PanOptica, Inc. [http://www.panopticapharma.com] 12.",Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
[http://www.Neurotechusa.com] 14.,Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
[http://bmctoday.net/retinatoday/ 2012/05/article.asp?f=drug-delivery-implants-for-geographic-atrophy] 15.,Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
[http://www.revophth.com/content/d/ retinal_insider/i/1709/c/31319/] 16.,Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
[http://www.retinalphysician.com/arti- cleviewer.aspx?articleID=108861] 23.,Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
"Page 5 of 5 (page number not for citation purposes)F1000Prime Reports 2014, 6:29 http://f1000.com/prime/reports/m/6/29",Non-OADS,/arxiv_data1/oa_pdf/e5/c1/medrep-06-29.PMC4017905.pdf
"Improvements incurrent treatments andemerging therapies foradult obstructive sleep apnea Neil Freedman Address: Northshore University Health System, 2151 Waukegan Road, Bannockburn, IL60015, USA Email: neilfreedman@comcast.net F1000Prime Reports 2014, 6:36(doi:10.12703/P6-36) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/94/medrep-06-36.PMC4017906.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/36 Abstract Obstructive sleep apnea (OSA) iscommon andisassociated with anumber ofadverse outcomes, including anincreased riskforcardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/d0/94/medrep-06-36.PMC4017906.pdf
"Page 2of8 (page number notforcitation purposes)F1000Prime Reports 2014, 6:36 http://f1000.com/prime/reports/m/6/36",Non-OADS,/arxiv_data1/oa_pdf/d0/94/medrep-06-36.PMC4017906.pdf
"Patients wererandomly assigned to either treatment with nEPAP (Provent; Theravent Inc., San Jose, CA, USA) or sham Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:36 http://f1000.com/prime/reports/m/6/36",Non-OADS,/arxiv_data1/oa_pdf/d0/94/medrep-06-36.PMC4017906.pdf
"Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:36 http://f1000.com/prime/reports/m/6/36",Non-OADS,/arxiv_data1/oa_pdf/d0/94/medrep-06-36.PMC4017906.pdf
"Given this information, weight loss Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:36 http://f1000.com/prime/reports/m/6/36",Non-OADS,/arxiv_data1/oa_pdf/d0/94/medrep-06-36.PMC4017906.pdf
"Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, Duran-Cantolla J, La Peña Md, Masdeu MJ, Gonzalez M, Campo Fd, Gallego I, Marin JM, Barbe F, Montserrat JM, Farre R: Association between obstructive Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:36 http://f1000.com/prime/reports/m/6/36",Non-OADS,/arxiv_data1/oa_pdf/d0/94/medrep-06-36.PMC4017906.pdf
"Remmers J, Charkhandeh S, Grosse J, Topor Z, Brant R, Santosham P, Bruehlmann S: Remotely controlled mandibular protrusion during sleep predicts therapeutic success with oral appliances Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:36 http://f1000.com/prime/reports/m/6/36",Non-OADS,/arxiv_data1/oa_pdf/d0/94/medrep-06-36.PMC4017906.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:36 http://f1000.com/prime/reports/m/6/36",Non-OADS,/arxiv_data1/oa_pdf/d0/94/medrep-06-36.PMC4017906.pdf
"Advances inunderstanding andtreating dystrophic epidermolysis bullosa Michael JVanden Oever andJakub Tolar* Address: Stem Cell Institute andDivision ofBlood andMarrow Transplantation, Department ofPediatrics, University ofMinnesota Medical School, 420 Delaware Street SE,MMC 366 Minneapolis, MN 55455, USA *Corresponding author: Jakub Tolar (tolar003@umn.edu) F1000Prime Reports 2014, 6:35(doi:10.12703/P6-35) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/35 Abstract Epidermolysis bullosa isagroup ofinherited disorders thatcanbeboth systemic andlife-threatening.,Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
"Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:35 http://f1000.com/prime/reports/m/6/35",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
"Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:35 http://f1000.com/prime/reports/m/6/35",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
"Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:35 http://f1000.com/prime/reports/m/6/35",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
"Ortiz-Urda S, Garcia J, Green CL, Chen L, Lin Q, Veitch DP, Sakai LY, Lee H, Marinkovich MP, Khavari PA: Type VII collagen is required Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:35 http://f1000.com/prime/reports/m/6/35",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
"Tamai K, Yamazaki T, Chino T, Ishii M, Otsuru S, Kikuchi Y, Iinuma S, Saga K, Nimura K, Shimbo T, Umegaki N, Katayama I, Miyazaki J, Takeda J, McGrath JA, Uitto J, Kaneda Y: PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:35 http://f1000.com/prime/reports/m/6/35",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
"Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:35 http://f1000.com/prime/reports/m/6/35",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
"89. van den Akker PC, Jonkman MF, Rengaw T, Bruckner-Tuderman L, Has C, Bauer JW, Klausegger A, Zambruno G, Castiglia D, Mellerio JE, McGrath JA, van Essen AJ, Hofstra RMW, Swertz MA: The Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:35 http://f1000.com/prime/reports/m/6/35",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:35 http://f1000.com/prime/reports/m/6/35",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/medrep-06-35.PMC4017907.pdf
"Novel approaches intreatment ofpediatric anxiety Jennifer M.Park1andDaniel A.Geller1,2* Addresses:1OCD andRelated Disorders Program, Massachusetts General Hospital, 185Cambridge St.,Suite 2200, Boston, MA02114, USA; 2Department ofPsychiatry, Harvard Medical School, Boston, MA, USA *Corresponding author: Daniel A.Geller (dageller@mgh.harvard.edu) F1000Prime Reports 2014, 6:30(doi:10.12703/P6-30) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/32/medrep-06-30.PMC4017908.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/30 Abstract Pediatric anxiety disorders have highprevalence rates andmorbidity andareassociated with considerable functional impairment anddistress.,Non-OADS,/arxiv_data1/oa_pdf/c3/32/medrep-06-30.PMC4017908.pdf
"Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:30 http://f1000.com/prime/reports/m/6/30",Non-OADS,/arxiv_data1/oa_pdf/c3/32/medrep-06-30.PMC4017908.pdf
"Abbreviations ABM, attention bias modification; ACT, acceptance and commitment therapy; CBT, cognitive behavioral therapy; Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:30 http://f1000.com/prime/reports/m/6/30",Non-OADS,/arxiv_data1/oa_pdf/c3/32/medrep-06-30.PMC4017908.pdf
"Eldar S,Apter A,Lotan D,Edgar KP,Naim R,Fox NA, Pine DS, Bar-Haim Y:Attention bias modification treatment for Page 4of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:30 http://f1000.com/prime/reports/m/6/30",Non-OADS,/arxiv_data1/oa_pdf/c3/32/medrep-06-30.PMC4017908.pdf
"Chasson GS,Buhlmann U,Tolin DF,Rao SR,Reese HE,Rowley T, Welsh KS, Wilhelm S:Need forspeed: Evaluating slopes Page 5of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:30 http://f1000.com/prime/reports/m/6/30",Non-OADS,/arxiv_data1/oa_pdf/c3/32/medrep-06-30.PMC4017908.pdf
"Page 6of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:30 http://f1000.com/prime/reports/m/6/30",Non-OADS,/arxiv_data1/oa_pdf/c3/32/medrep-06-30.PMC4017908.pdf
"Geriatric considerations inthetreatment ofadvanced prostate cancer Elizabeth R.Kessler1,2andThomas W.Flaig1,2* Addresses:1University ofColorado Cancer Center, University ofColorado Denver, Anschutz Medical Campus, Aurora, CO80045, USA;2Division ofMedical Oncology, School ofMedicine, University ofColorado Denver, Anschutz Medical Campus, Aurora, CO80045, USA *Corresponding author: Thomas W.Flaig (thomas.flaig@ucdenver.edu) F1000Prime Reports 2014, 6:33(doi:10.12703/P6-33) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/33 Abstract Prostate cancer isthemost common non-cutaneous cancer inUSmen andmainly affects elderly patients, with most new diagnoses occurring inthose over 65.Asthegeriatric population intheUScontinues to grow, theincidence ofthisdisease islikewise expected torise.",Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
"Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:33 http://f1000.com/prime/reports/m/6/33",Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
"Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:33 http://f1000.com/prime/reports/m/6/33",Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
"Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:33 http://f1000.com/prime/reports/m/6/33",Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
"One must note the risk of osteonecrosis of the jaw in a Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:33 http://f1000.com/prime/reports/m/6/33",Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
"Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, Parodi S, Dal Lago D, Gioia F, Monfardini S, Aapro MS, Serraino D, Zagonel V: Comprehensive geriatric assessment adds informa- tion to Eastern Cooperative Oncology Group performance Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:33 http://f1000.com/prime/reports/m/6/33",Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
[http://online.wsj.com/article/ PR-CO-20131022-904935.html] 33.,Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
"[http://article.wn.com/view/ 2013/12/06/NIHfunded_study_shows_increased_survival_in_men_ with_metasta_k/] Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:33 http://f1000.com/prime/reports/m/6/33",Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:33 http://f1000.com/prime/reports/m/6/33",Non-OADS,/arxiv_data1/oa_pdf/f9/b8/medrep-06-33.PMC4017909.pdf
"Point ofcare cutaneous imaging technology inmelanoma screening andmole mapping H.William Higgins II1*,Kachiu C.Lee2andDavid J.Leffell1 Addresses:1Department ofDermatology, Section ofCutaneous Oncology andDermatologic Surgery, Yale University School ofMedicine, 40Temple Street 5A,New Haven, CT06510, USA;2Department ofDermatology, Brown University, 593Eddy Street, APC 10,Providence, RI02903, USA *Corresponding author: H.William Higgins II(william.higgins@yale.edu) F1000Prime Reports 2014, 6:34(doi:10.12703/P6-34) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/5a/medrep-06-34.PMC4017910.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/34 Abstract Melanoma isamalignancy ofmelanocytes orpigment-producing cells located predominantly intheskin.,Non-OADS,/arxiv_data1/oa_pdf/f4/5a/medrep-06-34.PMC4017910.pdf
"Positive predictive values have been reported to be as high as 97.5% in Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:34 http://f1000.com/prime/reports/m/6/34",Non-OADS,/arxiv_data1/oa_pdf/f4/5a/medrep-06-34.PMC4017910.pdf
"Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:34 http://f1000.com/prime/reports/m/6/34",Non-OADS,/arxiv_data1/oa_pdf/f4/5a/medrep-06-34.PMC4017910.pdf
"Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:34 http://f1000.com/prime/reports/m/6/34",Non-OADS,/arxiv_data1/oa_pdf/f4/5a/medrep-06-34.PMC4017910.pdf
"Page 5of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:34 http://f1000.com/prime/reports/m/6/34",Non-OADS,/arxiv_data1/oa_pdf/f4/5a/medrep-06-34.PMC4017910.pdf
[http://nytimes.com/2013/07/21/business/ dissent-over-a-device-to-help-find-melanoma.html ?_r=0 ] 27.,Non-OADS,/arxiv_data1/oa_pdf/f4/5a/medrep-06-34.PMC4017910.pdf
"Page 6of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:34 http://f1000.com/prime/reports/m/6/34",Non-OADS,/arxiv_data1/oa_pdf/f4/5a/medrep-06-34.PMC4017910.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:34 http://f1000.com/prime/reports/m/6/34",Non-OADS,/arxiv_data1/oa_pdf/f4/5a/medrep-06-34.PMC4017910.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/a0/deu046.PMC4017942.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/deu063.PMC4017944.pdf
"Surface-associated microbes continue tosurprise usintheir sophisticated strategies forassembling biofilm communities Daniel J.Wozniak1*andMatthew R.Parsek2* Addresses:1Department ofMicrobial Infection andImmunity, Department ofMicrobiology, Center forMicrobial Interface Biology, TheOhio State University, 460 W12th Avenue, Columbus, OH43210, USA;2Department ofMicrobiology, University ofWashington, 1705 NEPacific Street, Seattle, WA98195, USA *Corresponding authors: Daniel J.Wozniak (daniel.wozniak@osumc.edu); Matthew R.Parsek (parsem@u.washington.edu) F1000Prime Reports 2014, 6:26(doi:10.12703/P6-26) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/81/biolrep-06-26.PMC4018179.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/26 Abstract Microorganisms arerarely found inisolation.,Non-OADS,/arxiv_data1/oa_pdf/ff/81/biolrep-06-26.PMC4018179.pdf
"Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:26 http://f1000.com/prime/reports/b/6/26",Non-OADS,/arxiv_data1/oa_pdf/ff/81/biolrep-06-26.PMC4018179.pdf
"These cases illustrate the interplay of PS signals on the dynamic Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:26 http://f1000.com/prime/reports/b/6/26",Non-OADS,/arxiv_data1/oa_pdf/ff/81/biolrep-06-26.PMC4018179.pdf
"Page 4of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:26 http://f1000.com/prime/reports/b/6/26",Non-OADS,/arxiv_data1/oa_pdf/ff/81/biolrep-06-26.PMC4018179.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:26 http://f1000.com/prime/reports/b/6/26",Non-OADS,/arxiv_data1/oa_pdf/ff/81/biolrep-06-26.PMC4018179.pdf
"Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:26 http://f1000.com/prime/reports/b/6/26",Non-OADS,/arxiv_data1/oa_pdf/ff/81/biolrep-06-26.PMC4018179.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:26 http://f1000.com/prime/reports/b/6/26",Non-OADS,/arxiv_data1/oa_pdf/ff/81/biolrep-06-26.PMC4018179.pdf
"Learning from myocarditis: mimicry, chaos andblack holes Noel R.Rose Address: Departments ofPathology andofMolecular Microbiology andImmunology, TheJohns Hopkins Schools ofMedicine andPublic Health, 615North Wolfe Street, Baltimore, MD21205, USA Email: nrrose@jhmi.edu F1000Prime Reports 2014, 6:25(doi:10.12703/P6-25) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/60/biolrep-06-25.PMC4018180.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/25 Abstract Autoimmune myocarditis anditssequel, dilated cardiomyopathy, aremajor causes ofheart failure, especially inchildren and young adults.",Non-OADS,/arxiv_data1/oa_pdf/7c/60/biolrep-06-25.PMC4018180.pdf
"To establish definitively that chronic myocarditis is caused by an autoimmune response, adoptive transferexperiments were conducted using donors immunized with either cardiac myosin or a purified peptide of Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:25 http://f1000.com/prime/reports/b/6/25",Non-OADS,/arxiv_data1/oa_pdf/7c/60/biolrep-06-25.PMC4018180.pdf
"For Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:25 http://f1000.com/prime/reports/b/6/25",Non-OADS,/arxiv_data1/oa_pdf/7c/60/biolrep-06-25.PMC4018180.pdf
"Inevitably, it Page 4of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:25 http://f1000.com/prime/reports/b/6/25",Non-OADS,/arxiv_data1/oa_pdf/7c/60/biolrep-06-25.PMC4018180.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:25 http://f1000.com/prime/reports/b/6/25",Non-OADS,/arxiv_data1/oa_pdf/7c/60/biolrep-06-25.PMC4018180.pdf
"Frisancho-Kiss S, Nyland JF, Davis SE, Frisancho JA, Barrett MA, Rose NR, Fairweather D: Sex differences in coxsackievirus B3- induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:25 http://f1000.com/prime/reports/b/6/25",Non-OADS,/arxiv_data1/oa_pdf/7c/60/biolrep-06-25.PMC4018180.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:25 http://f1000.com/prime/reports/b/6/25",Non-OADS,/arxiv_data1/oa_pdf/7c/60/biolrep-06-25.PMC4018180.pdf
"Cell-mediated immunity tohuman CMV infection: abrief overview Nadia Terrazzini and Florian Kern* Address: Pathogen Host Interaction Group (PHI), Immunology, Division ofMedicine, Brighton andSussex Medical School, Biology Road, Brighton, BN1 9PS, UK *Corresponding author: Florian Kern (f.kern@bsms.ac.uk) F1000Prime Reports 2014, 6:28(doi:10.12703/P6-28) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/28 Abstract Thecellular immune response tohuman cytomegalovirus (HCMV) hasdifferent components originating from both theadaptive andinnate immune systems.,Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
"Page 2of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:28 http://f1000.com/prime/reports/b/6/28",Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
"There are anumber of obvious differences between inbred mice and Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:28 http://f1000.com/prime/reports/b/6/28",Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
"Theinhibitory lectin-like receptor CD94/NKG2A/B interactswith the (non-classic) class Ib MHC molecule HLA-E,stable expression of which depends on the presentation Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:28 http://f1000.com/prime/reports/b/6/28",Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
"Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:28 http://f1000.com/prime/reports/b/6/28",Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
"Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:28 http://f1000.com/prime/reports/b/6/28",Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
"Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:28 http://f1000.com/prime/reports/b/6/28",Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
"Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, van Rysselberge M, Twité N, Goldman M, Marchant A, Willems F: Human Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:28 http://f1000.com/prime/reports/b/6/28",Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:28 http://f1000.com/prime/reports/b/6/28",Non-OADS,/arxiv_data1/oa_pdf/42/5d/biolrep-06-28.PMC4018181.pdf
"Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.114.007667From the Center for Tobacco Control Research and Education (R.G., N.B., S.A.G.)",Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
2013. http://bigstory.ap.org/article/old-tobacco-playbook-gets-new-use-e-cigarettes.,Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
http://www.jahonline.org/article/S1054-139X%   2813%2900748-9.,Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
Technical Report July-August 2013. http://publichealth.drexel.edu/~/ media/Files/publichealth/ms08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
"May 24, 2013. http://www.myfoxla.com/story/22305076/ its-the-latest-cannabis-craze-a-concerntrated-marijuana-known-as-wax.",Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
Updated December 2013. http://tobacco.ucsf.edu/e-cigarette-use-among-kids-skyrocketing-utah-levels-much-higher-among-adults.,Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
2013. http://www.dow.com/productsafety/finder/prog.htm#HealthInfo.,Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
July 2001. http://www.lyondellbasell.com/ techlit/techlit/2280.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
http://www.epa.gov/ ttnatw01/hlthef/acrolein.html.,OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
"February 16, 2012. http://www.cbsnews.com/news/electronic-cigarette-explodes-in-mans-mouth-causes-serious-injuries/.",Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
2013. http://www.wsbtv.com/news/news/ local/woman-says-e-cigarette-exploded-shot-flames-4-feet/nZkCX/.,Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
"Wall  Street J. August 27, 2013. http://online.wsj.com/news/articles/SB10001 424127887324906304579038844211701578.",Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
"September 22, 2013. http://www.usatoday.com/ story/opinion/2013/09/22/electronic-cigarettes-blu-ecigs-editorials- debates/2850859/.",Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
"November 9,   2013. http://www.nytimes.com/2013/11/10/world/europe/aided-by-   army-of-vapers-e-cigarette-industry-woos-and-wins-europe.html?pagewanted=1&_r=1&seid=auto&smid=tw-nytimeshealth.",Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
"February 26, 2014. http://www.europarl.",Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
"March 5, 2014. http://europa.eu/rapid/press-release_ MEMO-14-134_en.htm.",Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
June  2013. http://www.ash.org.uk/files/documents/ASH_715.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/81/cir-129-1972.PMC4018182.pdf
Available at:  http://www.cdc.gov/alcohol/ardi.htm .,Non-OADS,/arxiv_data1/oa_pdf/70/03/wjem-15-337-344.PMC4018185.pdf
Available at: http://www.cdc.gov/vitalsigns/drinkinganddriving/?s_,Non-OADS,/arxiv_data1/oa_pdf/70/03/wjem-15-337-344.PMC4018185.pdf
Available at: http://pubs.niaaa.,Non-OADS,/arxiv_data1/oa_pdf/70/03/wjem-15-337-344.PMC4018185.pdf
Available at:  http://www.who.int/roadsafety/projects/manuals/alcohol/drinking_ driving.pdf .,Non-OADS,/arxiv_data1/oa_pdf/70/03/wjem-15-337-344.PMC4018185.pdf
Available at: http://pubs.niaaa.nih.gov/ publications/Practitioner/CliniciansGuide2005/guide.pdf .,Non-OADS,/arxiv_data1/oa_pdf/70/03/wjem-15-337-344.PMC4018185.pdf
Available at: http://www.census.,OADS,/arxiv_data1/oa_pdf/70/03/wjem-15-337-344.PMC4018185.pdf
Available at: http://healthdisasteroc.org/civicax/filebank/blobdload.,Non-OADS,/arxiv_data1/oa_pdf/70/03/wjem-15-337-344.PMC4018185.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/88/ott-7-663.PMC4018308.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 663–666OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  663CASE REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6078 2Primary small-cell neuroendocrine carcinoma   of the male breast: a rare case report   with review of the literature Jian Jiang1 Guixin Wang1 Li Lv2 Caigang Liu1 Xi Liang1 Haidong Zhao1 1Department of Breast Surgery,  2Department of Pathology, the   Second Affiliated Hospital of   Dalian Medical University, Dalian,   People’s Republic of China Correspondence: Haidong Zhao   The Second Affiliated Hospital of Dalian  Medical University, Zhongshan Road   No 467, Shahekou District, Dalian,  Liaoning Province, People’s Republic of  China 116027   T el +86 186 2443 8696   Email z.hddl@hotmail.co mAbstract:  In this case study and review, we present a case of a primary small-cell neuroendocrine  carcinoma (SCNC) of the male breast.",Non-OADS,/arxiv_data1/oa_pdf/cb/88/ott-7-663.PMC4018308.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cb/88/ott-7-663.PMC4018308.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/88/ott-7-663.PMC4018308.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/d4/ppa-8-631.PMC4018309.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 631–642Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  631OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5779 7Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Vosbergen et al Running head recto: Patient preferences in message features DOI: http://dx.doi.org/10.2147/PPA.S57797 An online survey to study the relationship  between patients’ health literacy and coping style  and their preferences for self-management-related  information sandra Vosbergen1 niels Peek1 Johanna M r   Mulder-Wiggers1 hareld M c Kemps1,2 roderik A Kraaijenhagen3 Monique WM Jaspers1,4 Joyca PW lacroix5 1Department of Medical informatics,   Academic Medical center, Amsterdam,   the netherlands,  2Department of  cardiology, Máxima Medical centre,   Veldhoven, the netherlands,  3niPeD  research Foundation, Amsterdam,   the netherlands,  4center for human  Factors engineering of health  information T echnology (hiT lab),   Academic Medical center, Amsterdam,   the netherlands,  5Department of  Brain, Body and Behavior, Philips  research, eindhoven, the netherlandsObjective:  To evaluate patients’ preferences for message features and assess their relationships  with health literacy, monitor–blunter coping style, and other patient-dependent characteristics.",Non-OADS,/arxiv_data1/oa_pdf/6c/d4/ppa-8-631.PMC4018309.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6c/d4/ppa-8-631.PMC4018309.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2014:6 59–71Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  59Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S3911 4Current strategies for the prevention   of breast cancer Pooja Advani Alvaro Moreno-Aspitia Department of Hematology   and Oncology, Mayo Clinic,   Jacksonville, FL, USA Correspondence: Pooja Advani   Mayo Clinic, 4500 San Pablo Road,   Jacksonville, FL 32224, USA   Tel +1 904 953 7290   Fax +1 904 953 2315   email advani.pooja@mayo.ed uAbstract:  Due to the high incidence of breast cancer in the United States, optimal strategies for  its prevention are imperative.",Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
Or use: http://dvpr.es/1hPV62 v,Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
Available from:  http://seer.cancer.gov/csr/1975_2010 /.,Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
Available from: http://www.cancer.org/research/cancerfactsfigures/ cancerfactsfigures/cancer-facts-figures-201 3.,Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
Available from:  http://www.naaccr.org/LinkClick.aspx?fileticket=saVl1AbSyFA%3D &tabid=93&mid=433.,OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
Available from: http://epi.grants.,Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
"Available from: http://www.nccn.org/ professionals / physician_gls/pdf/breast-screening.pd f. Fort Washington, P A: National  Comprehensive Cancer Network; 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
Available from: http://clinicaltrials.gov/show/ NCT00285857.,Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
Available  from: http://clinicaltrials.gov/show/NCT00637481.,Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
Available  from: http://clinicaltrials.gov/show/NCT00673335.,Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
Available from: http://clinicaltrials.gov/show/NCT01372644.,Non-OADS,/arxiv_data1/oa_pdf/af/f8/bctt-6-059.PMC4018310.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/41/dddt-8-421.PMC4018311.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 421–429Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  421Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6332 0T opical infliximab for the suppression   of wound healing following experimental  glaucoma filtration surgery Burak T urgut1 Kenan eren1 Mehmet Mustafa Akın2 Tamer Demir1 Sabiha Kobat1 1Department of Ophthalmology,   School of Medicine, Fırat University,   Elazıg ˘, T urkey; 2Department of  Pathology, School of Medicine, Fırat  University, Elazıg ˘, T urkey correspondence: Burak Turgut   Fırat University Hospital, 23119, Elazıg ˘,  Turkey   Tel +90 42 4233 3555   Fax +90 42 4238 8096   email drburakturgut@gmail.co mBackground:  The purpose of this work was to look into the effects of infliximab on wound  healing in experimental glaucoma filtration surgery and to compare the antifibrotic effects of   this agent to that of mitomycin-C (MMC).",Non-OADS,/arxiv_data1/oa_pdf/69/41/dddt-8-421.PMC4018311.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/69/41/dddt-8-421.PMC4018311.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/41/dddt-8-421.PMC4018311.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 431–446Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  431Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5952 3Linagliptin: from bench to bedside John Doupis iatriko Palaiou Falirou Medical   Center, Division of Diabetes,   Athens, Greece Correspondence: John Doupis   iatriko Palaiou Falirou Medical Center,   Division of Diabetes, Areos 36.",Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
"Available from: http://bidocs.boehringer-ingelheim.com/ BIWebAccess/ ViewServlet .ser?docBase =renetnt&folderPath =/ Prescribing +Information/PIs/Tradjenta/Tradjenta.pd f. Accessed July 23,  2013.",Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
"Available from: http://www.merck.com/ product/usa/pi_circulars/j/januvia/januvia_pi.pd f. Accessed July 23,  2013.",OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
Available from: http://packageinserts.bms.,Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ nda/2011/201280Orig1s000SumR.pd f. Accessed April 18, 2013.",OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
Available from: http://clinicaltrials.gov/ ct2/show/NCT01792518?term =MARLINA&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01243424?term =linagliptin&rank =12.,Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
Available from: http://www.usrds.org/2009/pdf/V2_02_INC_PREV_09.,Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/c4/dddt-8-431.PMC4018312.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/09/dddt-8-411.PMC4018313.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 411–419Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  411Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5880 3combined isosorbide dinitrate and ibuprofen as a  novel therapy for muscular dystrophies: evidence  from Phase i studies in healthy volunteers Maria Vittoria cossu1 Dario cattaneo1 serena Fucile1 Paolo Pellegrino1 sara Baldelli1 Valeria cozzi1 amedeo capetti2 emilio clementi1,3  1Unit of clinical Pharmacology,   consiglio nazionale delle ricerche  institute of neuroscience,   Department of Biomedical and  clinical sciences, University hospital  “luigi sacco”, Università di Milano,   Milan, italy; 2Unit of infectious  Diseases, University hospital “ luigi  sacco”, Milan, italy; 3scientific  institute, irccs eugenio Medea,   Bosisio Parini, lecco, italy correspondence: emilio clementi   Unit of clinical Pharmacology,   “luigi sacco” University hospital,  Università di Milano, Via gB   grassi, 74–20157 Milan, italy   Tel +39 025 031 9643   Fax +39 025 031 9646   email emilio.clementi@unimi.i tAbstract:  We designed two Phase I studies that assessed healthy volunteers in order to evaluate  the safety and to optimize the dosing of the combination of the drugs isosorbide dinitrate, a nitric  oxide donor, and ibuprofen, a nonsteroidal antiinflammatory drug.",Non-OADS,/arxiv_data1/oa_pdf/c4/09/dddt-8-411.PMC4018313.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c4/09/dddt-8-411.PMC4018313.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/09/dddt-8-411.PMC4018313.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/c4/09/dddt-8-411.PMC4018313.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/1b/ijn-9-2005.PMC4018314.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2005–2017International Journal of Nanomedicine Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/3b/1b/ijn-9-2005.PMC4018314.pdf
"Or use: http://dvpr.es/1fApH3 gDove press submit your manuscript | www.dovepress.co m Dove press  2005OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6067 4role of the charge, carbon chain length,   and content of surfactant on the skin   penetration of meloxicam-loaded liposomes sureewan Duangjit1,2 Boonnada  Pamornpathomkul1 Praneet Opanasopit1 Theerasak rojanarata1 Yasuko Obata2 Kozo Takayama2 Tanasait Ngawhirunpat1 1Faculty of Pharmacy, silpakorn  University, Nakhon Pathom, Thailand;   2Department of Pharmaceutics, hoshi  University, shinagawa-ku, T okyo, Japan correspondence: Tanasait Ngawhirunpat   Faculty of Pharmacy, silpakorn University,   sanamchandra Palace campus,   6 ratchamankanai road, Muang,   Nakhon Pathom 73000, Thailand   Tel +66 34 255 800   email tanasait@su.ac.t hAbstract:  The objective of this study was to investigate the influence of surfactant charge,  surfactant carbon chain length, and surfactant content on the physicochemical characteristics  (ie, vesicle size, zeta potential, elasticity, and entrapment efficiency), morphology, stability, and  in vitro skin permeability of meloxicam (MX)-loaded liposome.",Non-OADS,/arxiv_data1/oa_pdf/3b/1b/ijn-9-2005.PMC4018314.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3b/1b/ijn-9-2005.PMC4018314.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/1b/ijn-9-2005.PMC4018314.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/fa/cia-9-753.PMC4018315.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 753–762Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  753RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S3955 8Profile of sapaci tabine: potential for the treatment  of newly diagnosed acute myeloid leukemia   in elderly patients Ming Y Lim Katarzyna Jamieson Department of Medicine, Division of  Hematology/Oncology, University of  North Carolina, Chapel Hill, NC, USA Correspondence: Katarzyna Jamieson   University of North Carolina School   of Medicine, Physicians Office Building,   CB# 7305, 170 Manning Drive,   3rd Floor, Chapel Hill, NC, USA   Tel +1 352 328 9355   email katarzyna_jamieson@med.unc.ed uAbstract:  Acute myeloid leukemia (AML) is a hematopoietic stem cell disorder that affects  approximately 14,000 persons each year in the US.",Non-OADS,/arxiv_data1/oa_pdf/e7/fa/cia-9-753.PMC4018315.pdf
"Available from:  http://www.fda.gov/AboutFDA/CentersOffices/ OfficeofMedicalProdu ctsandTobacco /CDER/ucm216790.ht m. Accessed March 11, 2014.",OADS,/arxiv_data1/oa_pdf/e7/fa/cia-9-753.PMC4018315.pdf
Available from: http://clinicaltrials.gov/show/ NCT01041703.,Non-OADS,/arxiv_data1/oa_pdf/e7/fa/cia-9-753.PMC4018315.pdf
Available from: http://clinicaltrials.gov/show/NCT01420926.,Non-OADS,/arxiv_data1/oa_pdf/e7/fa/cia-9-753.PMC4018315.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/e7/fa/cia-9-753.PMC4018315.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/fa/cia-9-753.PMC4018315.pdf
Available from: http://clinicaltrials.gov/show/ NCT01303796.,Non-OADS,/arxiv_data1/oa_pdf/e7/fa/cia-9-753.PMC4018315.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/8e/dddt-8-405.PMC4018316.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 405–410Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  405Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6257 1Clinical efficacy of Spasmofen® suppository   in the emergency treatment of renal colic:  a randomized, double-blind, double-dummy  comparative trial Mostafa Yakoot1 amel salem2 sameh Y ousef2 sherine helmy3 1green clinic and research center,   2alexandria helmy Medical center,   3Pharco corporation, alexandria,   egypt correspondence: Mostafa Yakoot   green clinic and research center,   27 green street, alexandria, egypt   Tel +20 12 2392 7561   email yakoot@yahoo.co mBackground:  Renal colic is typically characterized by the sudden onset of severe pain  radiating from the flank to the groin and its acute management in emergency departments  essentially aims at rapid pain relief.",Non-OADS,/arxiv_data1/oa_pdf/eb/8e/dddt-8-405.PMC4018316.pdf
Or use: http://dvpr.es/1i0msj y,Non-OADS,/arxiv_data1/oa_pdf/eb/8e/dddt-8-405.PMC4018316.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/eb/8e/dddt-8-405.PMC4018316.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/8e/dddt-8-405.PMC4018316.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/d3/tcrm-10-321.PMC4018317.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 321–329Therapeutics and Clinical Risk Management Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/ff/d3/tcrm-10-321.PMC4018317.pdf
"Or use: http://dvpr.es/1rmU40 PDove press submit your manuscript | www.dovepress.co m Dove press  321Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S3921 6Efficacy versus safety: the dilemma of using novel  platelet inhibitors for the treatment of patients  with ischemic stroke and coronary artery disease Gianmarco iannopollo1 Rita Camporotondo2 Gaetano M De Ferrari2 Sergio Leonardi2 1Università degli Studi di Pavia, Pavia,   2Fondazione iRCCS Policlinico San  Matteo, Pavia, Italy Correspondence: Sergio Leonardi   viale Golgi 19, Fondazione iRCCS   Policlinico San Matteo, Pavia, Italy   Tel +39 0382 503 489   email s.leonardi@smatteo.pv.i tAbstract:  Coronary and cerebrovascular atherothrombosis are the leading cause of mortality  and morbidity worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/tcrm-10-321.PMC4018317.pdf
Available from:  http://www.escardio.org/about/documents/eu-cardiovascular-disease- statistics-2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ff/d3/tcrm-10-321.PMC4018317.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/tcrm-10-321.PMC4018317.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/d3/tcrm-10-321.PMC4018317.pdf
Available from:  http://www.fda.gov/ohrms/dockets/ac/09/briefing/2009-4412b1-01- FDA.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ff/d3/tcrm-10-321.PMC4018317.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/d5/copd-9-441.PMC4018318.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 441–451International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  441OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6018 2living in negotiation: patients’ experiences   of being in the diagnostic process of COPD sari lindgren1,2 sissel lisa storli3 lena Wiklund-gustin4,5 1Department of health and Care  sciences, Faculty of health sciences,   UiT arctic University of norway,   Tromsø, norway; 2Faculty of health  and society, narvik University  College, narvik, norway; 3Department  of health and Care sciences, Faculty  of health sciences, UiT arctic  University of norway, Tromsø,   norway; 4Faculty of health and  society, narvik University College,   narvik, norway; 5school of health,   Care and social Welfare, Mälardalen  University, Västerås, sweden Correspondence: sari lindgren   Faculty of health and society, narvik   University College, lodvelangesgt  2,   PO Box  385, 8505 narvik, norway   Tel +47 7696 6105   Fax +47 7696 6819   email sarili@hin.n oPurpose:  To illuminate patients’ lived experiences of going through the process of being  diagnosed with chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/f8/d5/copd-9-441.PMC4018318.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/f8/d5/copd-9-441.PMC4018318.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f8/d5/copd-9-441.PMC4018318.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/d5/copd-9-441.PMC4018318.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/18/ijn-9-2149.PMC4018319.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2149–2156International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2149OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6076 4Preparation of biocompatible heat-labile enterotoxin  subunit B-bovine serum albumin nanoparticles for  improving tumor-targeted drug delivery via heat- labile enterotoxin subunit B  mediation liang Zhao1,* rongjian su2,* Wenyu cui3 Yijie shi1 liwei liu1 chang su4 1school of Pharmacy, liaoning Medical  University, Jinzhou, People’s republic  of china;  2central laboratory of  liaoning Medical University, Jinzhou,   People’s republic of china;  3National  Vaccine and serum Institute, Beijing,   People’s republic of china;  4school of  Veterinary Medicine, liaoning Medical  University, Jinzhou, People’s republic  of china *These authors contributed equally to  this work correspondence: chang su   school of Veterinary Medicine, liaoning   Medical University, Jinzhou  121000,   People’s republic of china   Tel/fax +86 416 467 2280  email changsu80@163.co mAbstract:  Heat-labile enterotoxin subunit B (LTB) is a non-catalytic protein from a pentameric  subunit of Escherichia coli .",Non-OADS,/arxiv_data1/oa_pdf/b4/18/ijn-9-2149.PMC4018319.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b4/18/ijn-9-2149.PMC4018319.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/18/ijn-9-2149.PMC4018319.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 847–856Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  847Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S3227 4Profile of ocriplasmin and its potential   in the treatment of vitreomacular adhesion Francisco R Stefanini1–3 Maurício Maia1 Paulo Falabella1–3 Marcel Pfister2,3 Moritz Niemeyer2 Amir H Kashani3 Mark S Humayun3 Michael J Koss2,3,4 1Retina Division, Department of  Ophthalmology and visual Sciences,   Federal University of Sao Paulo, Sao  Paulo, Brazil; 2Doheny eye institute,   Los Angeles, CA, USA; 3Department  of Ophthalmology, Keck School  of Medicine of the University of  Southern California, Los Angeles, CA,   USA; 4Department of Ophthalmology,   Goethe University, Frankfurt/Main,   Germany Correspondence: Francisco R Stefanini   Doheny eye institute, 1355 San Pablo St,  Unit 102, Los Angeles, CA 90033, USA   Tel +1 323 442 6575   email frstefanini@gmail.co mAbstract:  The recent approval by the US Food and Drug Administration of ocriplasmin for the  treatment of symptomatic vitreomacular adhesion (VMA), often associated with vitreomacular  traction (VMT) and macular hole (MH), has brought new attention to the field of pharmacologic  vitreolysis.",Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
"Available from: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm324369.ht m.  Accessed October 23, 2013.",Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
Available  from: http://www.ema.europa.eu/ema/index.jsp?curl =pages/medicines/ human/medicines/002381/smops/Positive/human_smop_000466.,Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
Available from:  http://ClinicalTrials.gov/ct2/show/NCT01429441?term =Ocriplasmin& rank=9.,Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
"National  Institute for Health and Care Excellence; 2013 [cited January 10, 2014];  Available from: http://www.nice.org.uk/newsroom/pressreleases/ NICE Y esEyeConditionTreatmentDraftGuidance.js p. Accessed October 30,  2013.",Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
Available from: http://clinicaltrials.gov/ct2/show/ results/NCT00412451?term =ocriplasmin&rank =7.,Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
Available  from: http://clinicaltrials.gov/ct2/show/study/NCT00913744?term =oc riplasmin&rank =5.,Non-OADS,/arxiv_data1/oa_pdf/31/01/opth-8-847.PMC4018320.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/fe/ijwh-6-469.PMC4018416.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 469–478International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  469OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5474 2Fear, guilt, and debt: an exploration of women’s  experience and perception of cesarean birth   in Burkina Faso, West africa Fabienne richard1 sylvie Zongo2 Fatoumata Ouattara3 1Maternal and reproductive Health  Unit, Department of Public Health,   Institute of Tropical Medicine,   antwerp, Belgium; 2Institut de  recherche pour le Développement,   Burkina Faso, West africa; 3Institut de  recherche pour le Développement  UMr 912, “ sciences economiques et  sociales de la santé et Traitement de  l’Information Médicale - sessTIM”,   Marseille, France correspondence: Fabienne richard   Maternal and reproductive Health Unit,  Department of Public Health, Institute   of Tropical Medicine, nationalestraat 155,   2000 antwerp, Belgium   Tel +32 3247 6664   Fax +32 3247 6258   email frichard@itg.b eBackground:  This paper explores women’ s experience and perception of cesarean birth in  Burkina Faso and its social and economic implications within the household.",Non-OADS,/arxiv_data1/oa_pdf/c3/fe/ijwh-6-469.PMC4018416.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c3/fe/ijwh-6-469.PMC4018416.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/fe/ijwh-6-469.PMC4018416.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/vhrm-10-271.PMC4018417.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 271–277Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  271ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S6013 0Influence of serological factors and BMI   on the blood pressure/hematocrit association   in healthy young men and women Beatriz Y Salazar Vázquez1,2,5 Miguel A Salazar Vázquez2,3 Adolfo Chávez-Negrete4 galileo escobedo2 Pedro cabrales5 shankar subramaniam5 Marcos intaglietta5 Ruy Pérez-Tamayo2  1Faculty of Medicine, Universidad  Juárez del Estado de Durango,   Victoria de Durango, Dgo, Mexico;   2Department of Experimental  Medicine, Faculty of Medicine,   Universidad Nacional Autónoma de  México, Hospital general de México  Dr Eduardo Liceaga, México City,   Mexico; 3Department of Pediatrics,   Hospital general de Zona no.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/vhrm-10-271.PMC4018417.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/vhrm-10-271.PMC4018417.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/vhrm-10-271.PMC4018417.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/d0/vhrm-10-263.PMC4018418.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 263–270Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  263ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S3664 1inhibition of hepatic microsomal triglyceride  transfer protein – a novel therapeutic   option for treatment of homozygous   familial hypercholesterolemia Alpo Vuorio1,2 Matti J Tikkanen3 Petri T Kovanen4 1Health Center Mehiläinen, Vantaa,   Finland; 2Finnish institute of  Occupational Health, Lappeenranta,   Finland; 3Heart and Lung Center,   Helsinki University Central Hospital,   Folkhälsan Research Center,   Biomedicum, Helsinki, Finland; 4wihuri  Research institute, Biomedicum,   Helsinki, FinlandAbstract:  Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by  mutations in the low-density lipoprotein (LDL)-receptor gene (LDLR) .",Non-OADS,/arxiv_data1/oa_pdf/80/d0/vhrm-10-263.PMC4018418.pdf
"Available from: http://www.nice.org.uk/nicemedia/ pdf/CG071NICEGuideline.pd f. Accessed October 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/80/d0/vhrm-10-263.PMC4018418.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/80/d0/vhrm-10-263.PMC4018418.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/d0/vhrm-10-263.PMC4018418.pdf
Available from: http://ir.aegerion.,Non-OADS,/arxiv_data1/oa_pdf/80/d0/vhrm-10-263.PMC4018418.pdf
reprints and permissions information is available online at http://www.nature .,Non-OADS,/arxiv_data1/oa_pdf/b3/59/41592_2013_Article_BFnmeth2722.PMC4018468.pdf
These data have  been previously described 20 and are available from the European  Nucleotide Archive ( http://www.ebi.ac.u k/ena /) under accessions  ERR03301 5 and ERR 03301 6.,OADS,/arxiv_data1/oa_pdf/b3/59/41592_2013_Article_BFnmeth2722.PMC4018468.pdf
All of the data used in this study  have been consolidated as a single experimental record in the ArrayExpress repository ( http://www.eb i.ac.uk/arrayexpress /)  under accession E-MTAB-172 8.,OADS,/arxiv_data1/oa_pdf/b3/59/41592_2013_Article_BFnmeth2722.PMC4018468.pdf
"Simulated RNA-seq data were generated using the BEERS  toolkit ( http:/ /cbil.upenn.edu/BEER S/), and additional mode - ling of base-call errors and quality scores was done with simNGS (http://www.ebi.ac .uk/goldman-srv/simNGS /).",OADS,/arxiv_data1/oa_pdf/b3/59/41592_2013_Article_BFnmeth2722.PMC4018468.pdf
Source code for the evaluations   performed in this study can be obtained from https://github.com/ RGASP-consortium /.,Non-OADS,/arxiv_data1/oa_pdf/b3/59/41592_2013_Article_BFnmeth2722.PMC4018468.pdf
/C2112014 Fantauzzo and Soriano This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months afterthe full-issue publication date (see http://genesdev.cshlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/55/0d/1005.PMC4018488.pdf
"After six months, it is available under a Creative Com- mons License (Attribution-NonCommercial 4.0 Unported), as described at http://creativecommons.org/licenses/by-nc/4.0/.1Corresponding author E-mail philippe.soriano@mssm.edu Article is online at http://www.gen esdev.org/cgi/doi /10.1101/gad.238709.114.",Non-OADS,/arxiv_data1/oa_pdf/55/0d/1005.PMC4018488.pdf
The protein interactions from this study have been submitted to the International Molecular Exchange Consortium (IMEx; http://www.imexconsortium.org) throughIntAct (Kerrien et al.,OADS,/arxiv_data1/oa_pdf/55/0d/1005.PMC4018488.pdf
IMEx (http://www.imexconsortium.org) through IntAct (Kerrien et al.,OADS,/arxiv_data1/oa_pdf/55/0d/1005.PMC4018488.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/8f/1d/1018.PMC4018489.pdf
9Corresponding author E-mail lazar@mail.med.upenn.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.237628.114.,Non-OADS,/arxiv_data1/oa_pdf/8f/1d/1018.PMC4018489.pdf
The initial dendrogram was first created based on Ward’s criterion using the fastcluster R package (http://danifold.net/fastcluster.html) and then subjected to optimal leaf ordering (Bar-Joseph et al.,OADS,/arxiv_data1/oa_pdf/8f/1d/1018.PMC4018489.pdf
Both LIN28 paralogs are known to have important and evolutionarily conserved roles in stemness (Shyh-Chang /C2112014 Hohenstein and Hastie This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f3/3f/923.PMC4018490.pdf
[Keywords : kidney development; Wilms tumor; Lin28] 3Corresponding author E-mail peter.hohenstein@roslin.ed.ac.uk Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.242735.114.,Non-OADS,/arxiv_data1/oa_pdf/f3/3f/923.PMC4018490.pdf
"One-third of genes near SRF-binding sites were induced in a short 30-min window, and thus these 960 genes were proposed /C2112014 Clark and Graves This article, published in Genes &Develop- ment , is available under a Creative Commons License (Attribution-Non Commercial 4.0 International), as described at http://creativecommons.org/ licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/3b/c1/926.PMC4018491.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/93/a0/929.PMC4018492.pdf
6Corresponding authors E-mail akhtar@immunbio.mpg.de E-mail kadlec@embl.fr Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.240200.114.,Non-OADS,/arxiv_data1/oa_pdf/93/a0/929.PMC4018492.pdf
"Instead, recent work suggests that the process fine-tunes expression kinetics by altering the rates of /C2112014 Chen and Gartenberg This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/f9/59/959.PMC4018494.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.3Corresponding author E-mail marc.gartenberg@rutgers.edu Article is online at http://www.gene sdev.org/cgi/doi/10.1101/gad.236729.113.",Non-OADS,/arxiv_data1/oa_pdf/f9/59/959.PMC4018494.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/41/29/971.PMC4018495.pdf
Article and publication date are online at http://www.genesdev.or g/cgi/doi/10.1101/gad.237149.113.,Non-OADS,/arxiv_data1/oa_pdf/41/29/971.PMC4018495.pdf
"The Stem Cell Research Community), doi: 10.3824/ stembook.1.34.1, http://www.stembook.org.",Non-OADS,/arxiv_data1/oa_pdf/41/29/971.PMC4018495.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/28/ea/983.PMC4018496.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.236554.113.,Non-OADS,/arxiv_data1/oa_pdf/28/ea/983.PMC4018496.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/bd/9b/995.PMC4018497.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.8Corresponding author E-mail treya@ucsd.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.231944.113.",Non-OADS,/arxiv_data1/oa_pdf/bd/9b/995.PMC4018497.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ GeNeTICs in MeDICINe  |   Volume 16  |  Number 5  |  May 2014",Non-OADS,/arxiv_data1/oa_pdf/9a/7d/gim2013148a.PMC4018498.pdf
A complete list of the genes and diseases from each of  the four categories is available online (http://ambrygen.com/ sites/default/files/pdfs/forms/most_updated/Incidental%20 Findings_051313.pdf).,OADS,/arxiv_data1/oa_pdf/6a/e2/gim2013153a.PMC4018499.pdf
SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS We thank the genetic counselors and geneticists for providing fruitful feedback during the construction of the exome-sequenc- ing patient consent form and for referring their patients to us for  whole-exome sequencing.,Non-OADS,/arxiv_data1/oa_pdf/6a/e2/gim2013153a.PMC4018499.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ GeNeTICs in MeDICINe  |   Volume 16  |  Number 5  |  May 2014",Non-OADS,/arxiv_data1/oa_pdf/6a/e2/gim2013153a.PMC4018499.pdf
Available in http://www.who.int/nmh/ publications/9789241597418/en.,Non-OADS,/arxiv_data1/oa_pdf/a3/be/IJPVM-5-373.PMC4018586.pdf
Available in http://www.healtheurope.org/index 7.,Non-OADS,/arxiv_data1/oa_pdf/a3/be/IJPVM-5-373.PMC4018586.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/a3/be/IJPVM-5-373.PMC4018586.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/a3/be/IJPVM-5-373.PMC4018586.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/eb/1c/IJPVM-5-394.PMC4018587.pdf
Available from: http://www.ihs‑classification.org/ en/02_klassifikation/02_teil1/01.01.00_migraine.html  [Last accesed on 2013 Jun 11].,OADS,/arxiv_data1/oa_pdf/4c/63/IJPVM-5-424.PMC4018590.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs339/en/.,Non-OADS,/arxiv_data1/oa_pdf/0f/10/IJPVM-5-457.PMC4018594.pdf
Available from: http://www.WHO.,Non-OADS,/arxiv_data1/oa_pdf/0f/10/IJPVM-5-457.PMC4018594.pdf
Available from:  http://www.who.int/features/factfiles/malaria/en/.,Non-OADS,/arxiv_data1/oa_pdf/73/9a/IJPVM-5-463.PMC4018595.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/ee/f7/IJPVM-5-478.PMC4018597.pdf
Available  from: http://www.acep.org/content.aspx?id=40992.,Non-OADS,/arxiv_data1/oa_pdf/9c/fa/IJPVM-5-489.PMC4018598.pdf
Available from:  http://www.brookespublishing.com/resource‑center/ screening‑and‑assessment/asq/asq‑se/ [Last accessed on  2014 Mar 14].,Non-OADS,/arxiv_data1/oa_pdf/ec/bb/IJPVM-5-494.PMC4018599.pdf
Available from:  http://www.apps.who.int/gb/archive/pdf_files/WHA54/ ea54id4.pdf [Last accessed on 2014 Mar 14].,OADS,/arxiv_data1/oa_pdf/ec/bb/IJPVM-5-494.PMC4018599.pdf
Available  from: http://www.sahiearcare.org/traffic_police.,Non-OADS,/arxiv_data1/oa_pdf/73/50/IJPVM-5-511.PMC4018602.pdf
Available from: http://dspace.thapar.edu: 8080/ dspace/bitstream/10266/1294/3/1294.pdf.,OADS,/arxiv_data1/oa_pdf/73/50/IJPVM-5-511.PMC4018602.pdf
Available from: http://www.who.int/ healthinfo/global_burden_disease/GlobalHealthRisks_ report_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7a/98/IJPVM-5-522.PMC4018604.pdf
Available from: http://www.who.int/ mediacentre/events/meetings/2011/alcohol_strategy_ network/en/.,Non-OADS,/arxiv_data1/oa_pdf/7a/98/IJPVM-5-522.PMC4018604.pdf
Available  from: http://www.pubs.niaaa.nih.gov/publications/aa30.,Non-OADS,/arxiv_data1/oa_pdf/7a/98/IJPVM-5-522.PMC4018604.pdf
Available from: http://www.euro.who.int/__ data/assets/pdf_file/0018/150552/RC61_R4.pdf.,OADS,/arxiv_data1/oa_pdf/7a/98/IJPVM-5-522.PMC4018604.pdf
Available  from: http://www.who.int/substance_abuse/publications/ treatment/en/.,Non-OADS,/arxiv_data1/oa_pdf/7a/98/IJPVM-5-522.PMC4018604.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/51/af/srep04918.PMC4018606.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4918 | DOI: 10.1038/srep04918 5",Non-OADS,/arxiv_data1/oa_pdf/51/af/srep04918.PMC4018606.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dc/b5/srep04939.PMC4018607.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4939 | DOI: 10.1038/srep04939 6",Non-OADS,/arxiv_data1/oa_pdf/dc/b5/srep04939.PMC4018607.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/48/26/srep04947.PMC4018608.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4947 | DOI: 10.1038/srep04947 6",Non-OADS,/arxiv_data1/oa_pdf/48/26/srep04947.PMC4018608.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3e/ca/srep04951.PMC4018609.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4951 | DOI: 10.1038/srep04951 9",Non-OADS,/arxiv_data1/oa_pdf/3e/ca/srep04951.PMC4018609.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/22/srep04937.PMC4018610.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4937 | DOI: 10.1038/srep04937 8",Non-OADS,/arxiv_data1/oa_pdf/fc/22/srep04937.PMC4018610.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a9/f8/srep04949.PMC4018611.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4949 | DOI: 10.1038/srep04949 7",Non-OADS,/arxiv_data1/oa_pdf/a9/f8/srep04949.PMC4018611.pdf
"Methods Ethics statement .Research conducted in this study was performed on anonymous adult individuals without intervening with patients, and is therefore not considered to involve ‘human subjects.’ Samples were collected with written informed consent obtained from participants with approval of institutional review boards (IRBs) at theLung Tissue Research Consortium (LTRC, http://www.ltrcpublic.com) and The University of Chicago.",Non-OADS,/arxiv_data1/oa_pdf/33/59/srep04893.PMC4018612.pdf
Study population .DNA extracted from peripheral blood of ILD patients (n 5227) were obtained from the Lung Tissue Research Consortium (http://www.ltrcpublic.,OADS,/arxiv_data1/oa_pdf/33/59/srep04893.PMC4018612.pdf
"Acknowledgments We thank the Lung Tissue Research Consortium (http://www.ltrcpublic.com) and the Translational Research Initiative in the Department of Medicine (TRIDOM) program at the University of Chicago for providing the ILD patients and control samples, respectively.",Non-OADS,/arxiv_data1/oa_pdf/33/59/srep04893.PMC4018612.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4893 | DOI: 10.1038/srep04893 5",Non-OADS,/arxiv_data1/oa_pdf/33/59/srep04893.PMC4018612.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1b/63/srep04944.PMC4018613.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4944 | DOI: 10.1038/srep04944 7",Non-OADS,/arxiv_data1/oa_pdf/1b/63/srep04944.PMC4018613.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/f4/srep04927.PMC4018627.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4927 | DOI: 10.1038/srep04927 12",Non-OADS,/arxiv_data1/oa_pdf/b8/f4/srep04927.PMC4018627.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/92/d0/IJPVM-5-256.PMC4018633.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/92/d0/IJPVM-5-256.PMC4018633.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/94/15/IJPVM-5-280.PMC4018636.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/50/21/IJPVM-5-293.PMC4018638.pdf
"Since  the prevalence of ID can be related to items such  as illiteracy, immigration, the PN and the number  of HCCs particularly in rural areas (providing  services before and during pregnancy for  prevention and help for early diagnosis), necessary  information to evaluate the effect of these variables  on the prevalence of ID were used from data of  immigration and illiteracy rates listed in the  statistical center of Iran and information inserted in  the National Statistical Yearbook 2007 (Available  from: http://salnameh.sci.org.ir).",OADS,/arxiv_data1/oa_pdf/79/68/IJPVM-5-313.PMC4018641.pdf
Available from:  http://www.aaidd.org/content_100.cfm?,Non-OADS,/arxiv_data1/oa_pdf/79/68/IJPVM-5-313.PMC4018641.pdf
"Available at  webpage: http://rctfi.org/goi_initiatives.htm, [Last  accessed on 2012 Jun 05].",Non-OADS,/arxiv_data1/oa_pdf/15/81/IJPVM-5-325.PMC4018642.pdf
"National Tobacco Control Program; Ministry of Health  and Family Welfare, Government of India.Available  from: http://www.pbhealth.gov.in/pdf/tobaccoo.pdf.",Non-OADS,/arxiv_data1/oa_pdf/15/81/IJPVM-5-325.PMC4018642.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/15/81/IJPVM-5-325.PMC4018642.pdf
Available from:  http://www.mhra.gov.uk/Howweregulate/Medicines/ Medicinesregulatorynews/CON171934.,Non-OADS,/arxiv_data1/oa_pdf/4e/42/IJPVM-5-370.PMC4018649.pdf
Available from: http://www.who.int/impact/ FinalBrochureWHA2008a.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/42/IJPVM-5-370.PMC4018649.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cf/83/srep04940.PMC4018655.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4940 | DOI: 10.1038/srep04940 10",Non-OADS,/arxiv_data1/oa_pdf/cf/83/srep04940.PMC4018655.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/b9/ov-3-021.PMC4018757.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncolytic Virotherapy 2014:3 21–33Oncolytic Virotherapy Dove press submit your manuscript | www.dovepress.co m Dove press  21ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OV.S5274 9Oncolytic viral therapy: targeting   cancer stem cells Tyrel T Smith1 Justin C Roth1 Gregory K Friedman1 G Yancey Gillespie2 1Department of Pediatrics, The  University of Alabama at Birmingham,   Birmingham, AL, USA; 2Department   of Neurosurgery, The University   of Alabama at Birmingham,   Birmingham, AL, USA Correspondence: G Yancey Gillespie   University of Alabama at Birmingham,  Department of Neurosurgery, wallace  Tumor institute 410F, 1720 2nd Ave S,  Birmingham, AL 35294-3300, USA   Tel +1 205 975 0438   Fax +1 205 934 7674   email yancey@uab.ed uAbstract:  Cancer stem cells (CSCs) are defined as rare populations of tumor-initiating cancer  cells that are capable of both self-renewal and differentiation.",Non-OADS,/arxiv_data1/oa_pdf/3f/b9/ov-3-021.PMC4018757.pdf
"Oncolytic Virotherapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncolytic-virotherapy-journa lOncolytic Virotherapy is an international, peer-reviewed, open access online journal  publishing original research, study protocols, reviews, editorials and commentaries  on all aspects of oncolytic virology, namely the application of oncolytic viruses for  the treatment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/3f/b9/ov-3-021.PMC4018757.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/b9/ov-3-021.PMC4018757.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4950 | DOI: 10.1038/srep04950 8",Non-OADS,/arxiv_data1/oa_pdf/3c/c6/srep04950.PMC4018762.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi - cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1182/blood-2012-03-41803 8 Bojesen, S.E., K.A.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1038/ng.256 6 Broome, H.J., and M.D.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.jmb.2012.12.01 4 Calado, R.T., J.A.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1371/journal.pone.000792 6 Carroll, K.A., and H. Ly.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1002/hep   .2608 9 Catlin, S.N., L. Busque, R.E.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1182/blood-2010-08-30353 7 Chen, Y ., Y .",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/   10.1073/pnas.091312510 7 Chin, L., S.E.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/S0092-8674   (00)80762- X Cronkhite, J.T., C. Xing, G. Raghu, K.M.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1164/rccm.200804-550O C Daniali, L., A. Benetos, E. Susser, J.D.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"4:1597. http://dx.doi.org/   10.1038/ncomms260 2 de Lange, T. 2010.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10   .1101/sqb.2010.75.01 7 De Meyer, T., E.R.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1093/hmg/ddm27 1 Diaz de Leon, A., J.T.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1371/journal   .pone.001068 0 Dokal, I.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1182/asheducation-2011.1.48 0 Doksani, Y., J.Y.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.cell.2013.09.04 8 Egan, E.D., and K. Collins.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1128/MCB.00151-1 0 Eisenberg, D.T., M.G.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1007/BF0195736 7 Albrecht, E., E. Sillanpää, S. Karrasch, A.C. Alves, V. Codd, I. Hovatta, J.L.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1183/09031936.0004621 3 Alder, J.K., N. Guo, F. Kembou, E.M. Parry, C.J.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1164/rccm.201103-0520O C Alter, B.P., N. Giri, S.A. Savage, J.A.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1038/ng.108 4 Armanios, M. 2012.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.mrfmmm.2011.10.01 3 Armanios, M. 2013.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1172/JCI6637 0 Armanios, M., and E.H. Blackburn.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1038/nrg324 6 Armanios, M., J.L.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1056/NEJMoa06615 7 Asselin-Labat, M.L., and C.E.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"2:120094. http://dx.doi.org/   10.1098/rsob.12009 4 Aviv, A.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.mrfmmm   .2011.05.00 1 Ballew, B.J., V .",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1371/journal.pgen.100369 5 Baur, J.A., Y. Zou, J.W.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/ 10  .1126/science.106232 9 Beier, F., M. Foronda, P. Martinez, and M.A.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1002/humu.2111 5 Kondo, M. 2010.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
http://dx.doi   .org/10.1111/j.1600-065X.2010.00963.,Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"225:951– 960. http://dx.doi.org/10.1016/0022-2836(92)90096- 3 Lin, J., P. Countryman, N. Buncher, P. Kaur, L. e, Y. Zhang, G. Gibson, C. You,  S.C. Watkins, J. Piehler, et al.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"2:4. http://dx.doi.org/10.1186/2041-9414-2- 4 Mason, J.M., and J.M.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1093/hmg/ddr15 3 Mitchell, J.R., E. Wood, and K. Collins.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1038/99014 1 Nakamura, T.M., G.B.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1146/annurev.genet.41   .110306.13035 0 Parks, C.G., D.B.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1158/1055-9965.EPI-08-061 4 Parry, E.M., J.K. Alder, X. Qi, J.J. Chen, and M. Armanios.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1182/   blood-2010-11-32214 9 Pavesi, E., F. Avondo, A. Aspesi, P. Quarello, A. Rocci, C. Vimercati, S. Pigullo,  C. Dufour, U. Ramenghi, and I. Dianzani.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1002/pbc.2210 7 Polvi, A., T. Linnankivi, T. Kivelä, R. Herva, J.P. Keating, O. Mäkitie, D.  Pareyson, L. Vainionpää, J. Lahtinen, I. Hovatta, et al.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.ajhg   .2012.02.00 2 Ramasubramanian, A., and C.L.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1136/bjophthalmol-   2011-30014 1 Sasa, G.S., A. Ribes-Zamora, N.D. Nelson, and A.A. Bertuch.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
http://dx.doi.org/10.1111/ j.1399-0004.2011.01658.,Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1074/jbc.C10005520 0 Gadalla, S.M., R. Cawthon, N. Giri, B.P.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1093/gerona/62.4.36 7 Ghosh, A.K., M.L.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1074/jbc.M111.29506 3 Gleeson, M., A. O’Marcaigh, M. Cotter, D. Brosnahan, T. Vulliamy, and O.P.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1002/ppul.2252 8 Goldman, F., R. Bouarich, S. Kulkarni, S. Freeman, H.Y .",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"9:21. http://dx.doi.org/10.1186/1743-8977-9-2 1 Gramatges, M.M., and A.A. Bertuch.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.trsl.2013.05.00 3 Griffith, J.D., L. Comeau, S. Rosenfield, R.M.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80760- 6 Gu, P., J.N.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1038/emboj.2012.9 6 Heiss, N.S., S.W.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1038/ng0598-3 2 Horn, S., A. Figl, P.S.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1126/science.123006 2 Houghtaling, B.R., L. Cuttonaro, W. Chang, and S. Smith.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/   10.1016/j.cub.2004.08.05 2 Isoda, T., N. Mitsuiki, T. Ohkawa, S. Kaneko, A. Endo, T. Ono, Y. Aoki, D.  Tomizawa, M. Kajiwara, S. Araki, et al.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1097/MPH.0b013e318279e5c a Joksic, I., D. Vujic, M. Guc-Scekic, A. Leskovac, S. Petrovic, M. Ojani, J.P.  Trujillo, J. Surralles, M. Zivkovic, A. Stankovic, et al.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"3:6. http://dx.doi.org/10.1186/2041-9414-3- 6 Jongmans, M.C., E.T.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1016/j.ajhg.2012.01.00 4 Kajtár, P., and K. Méhes.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1002/ajmg.132049040 4 Kappei, D., F. Butter, C. Benda, M. Scheibe, I. Draškovic ˇ, M. Stevense, C.L.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1038/emboj.2013.10 5 Keller, R.B., K.E.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1002/pbc.2419 3 Kirwan, M., and I. Dokal.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
http://dx.doi.org/10.1111/j.1399-0004   .2007.00923. x,Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"359:2168– 2170. http://dx.doi.org/10.1016/S0140-6736(02)09087- 6 Vulliamy, T., R. Beswick, M. Kirwan, A. Marrone, M. Digweed, A. Walne, and  I. Dokal.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
http://dx.doi.org/10.1111/j.1399-0004.2010.01605.,Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1093/hmg/ddm11 1 Walne, A.J., T. Vulliamy, R. Beswick, M. Kirwan, and I. Dokal.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1182/blood-2008-05-15344 5 Walne, A.J., T. Bhagat, M. Kirwan, C. Gitiaux, I. Desguerre, N. Leonard, E. Nogales,  T. Vulliamy, and I.S.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.3324/haematol.2012.07106 8 Walne, A.J., T. Vulliamy, M. Kirwan, V .",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.ajhg.2013.02.00 1 Wang, F., J.A.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/   j.celrep.2012.10.00 7 Wang, L.L., and S.E.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10   .1016/0168-9525(92)90232- S Wright, W.E., M.A.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1002/(SICI)1520- 6408(1996)18:2<173::AID-DVG10>3.0.CO;2- 3 Wu, P., H. Takai, and T. de Lange.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.cell.2012.05.02 6 Xin, H., D. Liu, M. Wan, A. Safari, H. Kim, W. Sun, M.S.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1038/nature0546 9 Yamaguchi, H., R.T. Calado, H. Ly, S. Kajigaya, G.M.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1056/NEJMoa04298 0 Ye, J.Z., and T. de Lange.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"3:35. http://dx.doi.org/   10.3389/fonc.2013.0003 5 Young, N.S.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1136/oemed-2012-10135 0 Zhong, F., S.A. Savage, M. Shkreli, N. Giri, L. Jessop, T. Myers, R. Chen, B.P.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
http://dx.doi.org/10.1101/gad.200641 1is mutated in dyskeratosis congenita.,Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.ajhg.2007.10.00 4 Scheinfeld, M.H., Y.W.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1007/s00247-007-0592- 0 Seimiya, H., and S. Smith.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1074/ jbc.M11226620 0 Seki, M., Y. Takeda, K. Iwai, and K. Tanaka.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1074/jbc.M112   .41660 2 Sfeir, A., and T. de Lange.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1126/   science.121849 8 Shay, J.W., and W.E.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi   .org/10.1093/carcin/bgh29 6 Shchepachev, V., H. Wischnewski, E. Missiaglia, C. Soneson, and C.M.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.celrep.2012.08.03 1 Sidorov, I., M. Kimura, A. Yashin, and A. Aviv.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.exphem.2008.11.00 9 Smith, S., I. Giriat, A. Schmitt, and T. de Lange.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1038/nsmb.257 1 Stern, J.L., K.G.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1128/   MCB.00379-1 2 Stewart, J.A., F. Wang, M.F.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1038/emboj.2012.21 5 Takai, H., A. Smogorzewska, and T. de Lange.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/   S0960-9822(03)00542- 6 Tang, J., Z.Y.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1093/nar/gkm113 7 Tejera, A.M., M. Stagno d’Alcontres, M. Thanasoula, R.M.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.03.01 1 Theall, K.P., S. McKasson, E. Mabile, L.F. Dunaway, and S.S. Drury.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.2105/AJPH.2012.30120 8 Touzot, F., I. Callebaut, J. Soulier, L. Gaillard, C. Azerrad, A. Durandy, A. Fischer,  J.P. de Villartay, and P. Revy.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1261/rna.135400 9 Tsakiri, K.D., J.T.",OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
"http://dx.doi.org/10.1007/s00439-008-0576- 7 Vannier, J.B., V .",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
http://dx.doi   .org/10.1016/j.cell.2012.03.03 0,OADS,/arxiv_data1/oa_pdf/7e/4e/JCB_201401012.PMC4018777.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201304055/DC1.anti-IMP7 (GeneTex) at 1:500, or anti-FLAG M2 (Sigma-Aldrich) at 1:200  for 90 min, followed by a 60-min incubation with Alexa Fluor 488– or Alexa  Fluor 568–conjugated secondary antibodies (Molecular Probes) at 1:1,000.",Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1128/MCB.20.1.233-241.200 0 Harreman, M.T., P.E.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1074/jbc.M30111420 0 Harreman, M.T., M.R.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1074/jbc.M21095120 0 Honsho, M., J.Y.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1074/jbc.273.33   .2086 0 Jacobs, M.D., and S.C. Harrison.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81698- 0 Kaur, G., K.G.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi   .org/10.1074/jbc.M112.43674 1 Kim, I.-S., D.-H. Kim, S.-M. Han, M.-U.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1074/jbc   .M90925619 9 Kobe, B.",Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1038/762 5 Koerner, C., T. Guan, L. Gerace, and G. Cingolani.",Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"278:16216– 16221. http://dx.doi.org/10.1074/jbc.M30113720 0 Kuusisto, H.V., K.M.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10   .1002/ijc.2388 4 Kuusisto, H.V., K.M.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1096/   fj.11-19158 5 Lee, S.J., Y. Matsuura, S.M.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1038/nature0357 8 Lehar, S.M., M. Nacht, T. Jacks, C.A.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1074/jbc   .274.46.3269 9 Lohrum, M.A.E., D.B.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1128/MCB.21.24.852 1-  8532.200 1 Nakielny, S., M.C.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi   .org/10.1006/excr.1996.036 9 Nie, L., M. Sasaki, and C.G.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1074/jbc.M61051520 0 Ogawa, Y., Y. Miyamoto, M. Oka, and Y. Yoneda.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1111/j.1600-0854.2012   .01367. xThe authors thank Vishwajeeth Pagala in the Hartwell Center for Bioinformatics  and Biotechnology for MS analyses, Yoichi Miyamoto for Ran protein expression  constructs, Dirk Görlich for anti-IMP 1 antibody, Sundy Yang for Hexa-histidine  tagged-IMP proteins, Tracey Waterhouse and Cassandra David for assistance  with tissue culture, and Monash Micro Imaging.",Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1016/j.jmb.2006.05.01 4 Cai, Y., Y. Gao, Q. Sheng, S. Miao, X. Cui, L. Wang, S. Zong, and S.S. Koide.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10   .1002/mrd.113 9 Catimel, B., T. Teh, M.R.M.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"276:34189– 34198. http://dx.doi.org/10.1074/jbc.M10353120 0 Cingolani, G., C. Petosa, K. Weis, and C.W.",Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1016/S1097-   2765(02)00727- X Conti, E., and J. Kuriyan.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1016/S0969-2126   (00)00107- 6 Ding, Q., S.i.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10   .1016/S0960-9822(99)80482- 5 Forwood, J.K., and D.A.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1021/bi025548 s Fridell, R.A., R. Truant, L. Thorne, R.E.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi   .org/10.1096/fj.09-13656 4 Gentile, M., M. Ahnström, F. Schön, and S. Wingren.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"20:7753– 7760. http://dx.doi.org/10.1038/sj.onc.120499 3 Gluz, O., P. Wild, R. Meiler, R. Diallo-Danebrock, E. Ting, S. Mohrmann, G.  Schuett, E. Dahl, T. Fuchs, A. Herr, et al.",Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
http://dx.doi.org/10.1016/j.tcb.2004.07.01 6,OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10   .1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2 -2 Polyak, K., Y. Xia, J.L.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10   .1038/3852 5 Poon, I.K.H., and D.A.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
http://dx.doi   .org/10.1111/j.1600-0854.2005.00268.,Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"25:115– 123. http://dx.doi.org/10.1247/csf.25.11 5 Tao, T., J. Lan, G.L.",Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10   .1165/rcmb.2006-0073O C Tian, Y., Z. Li, W. Hu, H. Ren, E. Tian, Y. Zhao, Q. Lu, X. Huang, P. Yang,   X. Li, et al.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1016/j   .cell.2010.04.03 4 Wagstaff, K.M., and D.A.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1016/j   .ab.2005.10.02 9 Wagstaff, K.M., H. Sivakumaran, S.M.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1042/BJ2012015 0 Yang, S.N.Y., A.A.S.",Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1074/ jbc.M109.07957 4 Zhao, X., R.E.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-04-337 7 Zhao, Y.G., H. Zhao, L. Miao, L. Wang, F. Sun, and H. Zhang.",OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
http://dx.doi.org/10.1074/jbc   .M112.41596 8,Non-OADS,/arxiv_data1/oa_pdf/02/67/JCB_201304055.PMC4018778.pdf
"These results highlight  mechanisms of an essential function of Chk2 in mitosis.Chk2 prevents mitotic exit when the majority of  kinetochores are unattached Eleni Petsalaki and George Zachos Department of Biology, University of Crete, Heraklion 70013, Greece © 2014 Petsalaki and Zachos  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201310071/DC 1.For Aurora B–pS331 or Chk2-pT383 staining, cells were extracted  in prewarmed (37°C) Phem buffer supplemented with 0.5% CHAPS and  100 nM microcystin (Sigma-Aldrich) for 5 min at room temperature, fixed  with 4% prewarmed (37°C) 4% paraformaldehyde in Phem buffer for  10 min at room temperature, permeabilized in 0.5% Triton X-100 in Phem  buffer for 2 min at room temperature, washed twice with PBS, and immuno - stained as appropriate.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/   10.1073/pnas.060182810 3 Maciejowski, J., K.A.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/   10.1083/jcb.20100105 0 Magidson, V., C.B.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.07.01 2 Malureanu, L., K.B.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1083/jcb.20100309 0 Matson, D.R., P.B.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1101/gad.184184   .111 McGowan, C.H., and P. Russell.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi   .org/10.1091/mbc.6.1.11 9 Mueller, P.R., T.R.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10   .1126/science.270.5233.8 6 Nezi, L., and A. Musacchio.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi   .org/10.1016/j.ceb.2009.09.00 7 Peters, J.M.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1016 /S1097-2765   (02)00540- 3 Petsalaki, E., and G. Zachos.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1083/jcb.20110402 3 Posch, M., G.A.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi   .org/10.1083/jcb.20091204 6 Rainey, M.D., E.J.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1038/   sj.onc.121070 2 Santaguida, S., A. Tighe, A.M. D’Alise, S.S. Taylor, and A. Musacchio.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1083/jcb.20100103 6 Santaguida, S., C. Vernieri, F. Villa, A. Ciliberto, and A. Musacchio.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi   .org/10.1038/emboj.2011.7 0 Saurin, A.T., M.S.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"2:316. http://dx.doi   .org/10.1038/ncomms131 9 Schwarz, J.K., C.M.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10   .1242/jcs.05181 3 Stolz, A., N. Ertych, A. Kienitz, C. Vogel, V. Schneider, B. Fritz, R. Jacob, G.   Dittmar, W. Weichert, I. Petersen, and H. Bastians.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
http://dx.doi.org/10.1038/ncb205 1We thank G. Sourvinos for helping with the time lapse.,Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00410- X Ahn, J., and C. Prives.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi   .org/10.1074/jbc.M20832120 0 Ahn, J.Y., X. Li, H.L.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1074/jbc.M20082220 0 Brito, D.A., and C.L.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1016/j.cub.2006.04   .043 Chen, Y., and R.Y.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1128/MCB.00891-1 0 Cimini, D. 2008.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/   10.1083/jcb.20020809 1 Fletcher, L., Y. Cheng, and R.J. Muschel.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1038/nrm349 4 Gavet, O., and J. Pines.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1016/   j.devcel.2010.02.01 3 Giunta, S., R. Belotserkovskaya, and S.P.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"190:197– 207. http://dx.doi.org/10.1083/jcb.20091115 6 Hewitt, L., A. Tighe, S. Santaguida, A.M. White, C.D.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1083/jcb.20100213 3 Jelluma, N., A.B.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1016/j.cell.2007.11.04 6 Kabeche, L., and D.A.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1016/j.cub.2012.02.03 0 Kapoor, T.M., T.U.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi   .org/10.1083/jcb.150.5.97 5 Lampson, M.A., and T.M.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1038/ncb120 8 Lee, C.H., and J.H.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
http://dx.doi.org/10.1074/jbc   .M10441420 0,Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1074/jbc.M21120220 0 van der Waal, M.S., R.C.",Non-OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1016/j.yexcr.2012.03.01 5 van Vugt, M.A., A.K.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1371/journal.pbio.100028 7 Yeh, Y.H., Y.F.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi.org/10.1038/   onc.2008.47 7 Zachos, G., E.J.",OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
http://dx.doi.org/10.1016/j.devcel.2007.01.00 3,OADS,/arxiv_data1/oa_pdf/e1/63/JCB_201310071.PMC4018780.pdf
"http://dx.doi   .org/10.1083/jcb.143.6.160 3 Bähler, J., J.-Q.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1002/(SICI)1097- 0061(199807)14:10<943::AID-YEA292>3.0.CO;2- Y Balasubramanian, M.K., E. Bi, and M. Glotzer.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/j.cub.2004.09.02 2 Barr, F.A., and U. Gruneberg.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/j.cell.2007.11.01 1 Bezanilla, M., and T.D.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1091/mbc.11.1.7 9 Bezanilla, M., S.L.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/   10.1091/mbc.8.12.269 3 Bezanilla, M., J.M.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/S0960-9822(00)   00420- 6 Bretscher, A.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1083/jcb.20030103 5 Cheney, R.E., M.K.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/0092-8674(93)90675- G Chung, S., and P.A.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"189:755– 767. http://dx.doi.org/10.1083/jcb.20091201 1 Churchman, L.S., Z. Okten, R.S.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1073/   pnas.040948710 2 Clayton, J.E., M.R.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/j.cub   .2010.07.02 6 Clayton, J.E., L.W.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1091/mbc.E13-04-020 0 Coffman, V.C., and J.-Q.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1091/mbc.E09-05-042 8 Coffman, V.C., P. Wu, M.R.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb   .20110607 8 Coffman, V.C., J.A.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb.20130502 2 Daga, R.R., A. Yonetani, and F. Chang.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1016/j.cub.2006.06.02 6 Donovan, K.W., and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.09.00 1 Doyle, A., R. Martín-García, A.T. Coulton, S. Bagley, and D.P.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201308146/DC1.,Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb.20100817 1 Laporte, D., N. Ojkic, D. Vavylonis, and J.-Q.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1091/mbc.E12-02-012 3 Laue, T.M., and W.F.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1242/jcs.10257 4 Lee, I-J., V.C.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1002/cm.2105 2 Liu, H.-L., A.H. Osmani, L. Ukil, S. Son, S. Markossian, K.F.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1128/EC.00032-1 0 Lo Presti, L., and S.G. Martin.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1091/ mbc.E12-07-049 9 Lord, M., E. Laves, and T.D.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1091/mbc.E05-07-060 1 Matsuyama, A., R. Arai, Y. Yashiroda, A. Shirai, A. Kamata, S. Sekido, Y.  Kobayashi, A. Hashimoto, M. Hamamoto, Y. Hiraoka, et al.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1038/nbt122 2 May, K.M., T.Z.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"39:195– 200. http://dx.doi.org/10.1002/(SICI)1097-0169(1998)39:3<195::AID-   CM2>3.0.CO;2- 4 Mehta, A.D., R.S.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1038/2307 2 Moreno, S., A. Klar, and P. Nurse.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/0076-6879(91)94059- L Motegi, F., K. Nakano, and I. Mabuchi.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb.20040209 7 Müller, M., K. Richter, A. Heuck, E. Kremmer, J. Buchner, R.P.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00322- 0 Mulvihill, D.P., S.R.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1002/cm.2011 3 Nakamura, T., M. Nakamura-Kubo, A. Hirata, and C. Shimoda.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi .org/  10.1091/mbc.12.12.395 5 Nolen, B.J., N. Tomasevic, A. Russell, D.W. Pierce, Z. Jia, C.D.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1038/nature0823 1 Odronitz, F., and M. Kollmar.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1186/gb-2007-8-9-r19 6 Paoletti, A., and F. Chang.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
http://dx.doi   .org/10.1091/mbc.11.8.275 7discrete roles during cell fusion and spore formation.,OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1242/jcs.05520 2 Dunn, B.D., T. Sakamoto, M.S.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb   .20070708 0 Eves, P.T., Y. Jin, M. Brunner, and L.S.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb.20120102 4 Fang, X., J. Luo, R. Nishihama, C. Wloka, C. Dravis, M. Travaglia, M. Iwase,  E.A.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb.20100513 4 Gachet, Y., S. Tournier, J.B. Millar, and J.S.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760015 6 Glotzer, M. 2005.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1126/science.109689 6 Golomb, L., M. Abu-Abied, E. Belausov, and E. Sadot.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"8:3. http://dx.doi.org/10.1186/1471-2229-8- 3 Gould, K.L., and V .",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1101/gad.11.22.293 9 Grallert, A., R. Martín-García, S. Bagley, and D.P.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1242/jcs.01246 8 Gross, S.P., M. Vershinin, and G.T.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1016/j.cub.2007.04.02 5 Hales, K.G., E. Bi, J.-Q.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/S0955-0674(99)00042- 3 Hammer, J.A.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/   10.1073/pnas.070678010 4 Heym, R.G., D. Zimmermann, F.T.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb.20130209 5 Hodges, A.R., E.B.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1074/jbc.M70886520 0 Hodges, A.R., C.S.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1016/j.cub.2009.10.06 9 Hodges, A.R., E.B.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/j.cub.2012.05.03 5 Huang, J., Y. Huang, H. Yu, D. Subramanian, A. Padmanabhan, R. Thadani,  Y. Tao, X. Tang, R. Wedlich-Soldner, and M.K.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1083/jcb.20120904 4 Krementsova, E.B., A.R.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb.20110614 6 Krendel, M., and M.S.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/   10.1152/physiol.00014.200 5 Kruse, C., A. Jaedicke, J. Beaudouin, F. Bohl, D. Ferring, T. Guttler, J. Ellenberg,  and R.P.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1083/jcb.20020710 1 Laporte, D., R. Zhao, and J.-Q.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
http://dx.doi.org/10.1016/j.semcdb.2010.08.00 4,OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1126/science.115108 6 Wagner, W., P. Bielli, S. Wacha, and A. Ragnini-Wilson.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1093/   emboj/cdf65 0 Walker, M.L., S.A. Burgess, J.R.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1038/3501559 2 Warshaw, D.M., G.G.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb.20120803 0 Wolfe, B.A., and K.L.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/j.tcb.2004   .11.00 6 Woods, A., T. Sherwin, R. Sasse, T.H.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10   .1126/science.111323 0 Wu, J.-Q., J. Bähler, and J.R. Pringle.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1091/mbc.12.4.106 1 Wu, J.-Q., J.R. Kuhn, D.R.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10   .1016/S1534-5807(03)00324- 1 Wu, J.-Q., V. Sirotkin, D.R.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1083/jcb.20060203 2 Wu, J.-Q., C.D.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10   .1016/S0091-679X(08)00609- 2 Wu, P., R. Zhao, Y. Ye, and J.-Q.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1371/journal.pone.002800 0 Ye, Y., I-J.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/   10.1091/mbc.E11-09-080 0 Yildiz, A., J.N.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1126/   scien ce.108439 8 Yin, H., D. Pruyne, T.C.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1038/3502302 4 Yu, J.H., A.H. Crevenna, M. Bettenbühl, T. Freisinger, and R. Wedlich-Söldner.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1242/jcs.07903 8Pashkova, N., Y. Jin, S. Ramaswamy, and L.S.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"25:693– 700. http://dx.doi.org/10.1038/sj.emboj.760096 5 Pollard, T.D., and J.-Q.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10   .1038/nrm283 4 Pruyne, D., A. Legesse-Miller, L. Gao, Y. Dong, and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1146/annurev.cellbio   .20.010403.10310 8 Reck-Peterson, S.L., M.J. Tyska, P.J.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/jcb   .153.5.112 1 Rief, M., R.S.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/   10.1073/pnas.97.17.948 2 Roberts-Galbraith, R.H., and K.L.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1083/   jcb.148.4.63 5 Rudolf, R., C.M.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
http://dx.doi   .org/10.1111/j.1471-4159.2010.07110.,Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1006/bbrc.2000.281 9 Sakamoto, T., F. Wang, S. Schmitz, Y. Xu, Q. Xu, J.E.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1074/jbc.M30366220 0 Šamaj, J., N.D. Read, D. Volkmann, D. Menzel, and F. Baluska.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi   .org/10.1016/j.tcb.2005.06.00 6 Samejima, I., V.J.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/j.cub.2010.10.00 6 Schmidt, M., B. Bowers, A. Varma, D.H. Roh, and E. Cabib.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/S0006-3495(00)76713- 0 Sladewski, T.E., C.S.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1038/nsmb.261 4 Stark, B.C., T.E.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1091/mbc   .E09-10-085 2 Stelter, P., R. Kunze, D. Flemming, D. Höpfner, M. Diepholz, P. Philippsen, B.  Böttcher, and E. Hurt.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1038/ncb160 4 Tebbs, I.R., and T.D.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1091/mbc   .E12-10-077 5 Tolić-Nørrelykke, I.M., L. Sacconi, C. Stringari, I. Raabe, and F.S.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1016/   j.cub.2005.05.05 2 Tominaga, M., and A. Nakano.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"3:211. http://dx.doi.org/10.3389/fpls.2012   .0021 1 Tóth, J., M. Kovács, F. Wang, L. Nyitray, and J.R.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
"http://dx.doi.org/10.1074/jbc   .M50520920 0 Tran, P.T., L. Marsh, V. Doye, S. Inoué, and F. Chang.",OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
http://dx.doi.org/10.1083/jcb.153.2.39 7,Non-OADS,/arxiv_data1/oa_pdf/24/1d/JCB_201308146.PMC4018781.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201309079/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi   .org/10.1016/j.devcel.2004.12.00 7 Balla, T. 2013.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1152/physrev.00028   .2012 Behrndt, M., G. Salbreux, P. Campinho, R. Hauschild, F. Oswald, J. Roensch,  S.W.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10   .1126/science.122414 3 Boulant, S., C. Kural, J.C. Zeeh, F. Ubelmann, and T. Kirchhausen.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1038/ncb230 7 Comer, F.I., and C.A.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10   .1016/j.cell.2007.01.01 0 Fabrowski, P., A.S. Necakov, S. Mumbauer, E. Loeser, A. Reversi, S. Streichan,  J.A.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"4:2244. http://dx.doi.org/10.1038/ncomms324 4 Fernandez-Gonzalez, R., S.M.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.09.00 3 Field, S.J., N. Madson, M.L.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi   .org/10.1016/j.cub.2005.06.05 9 Figard, L., H. Xu, H.G.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j.devcel   .2013.11.00 6 Gassama-Diagne, A., W. Yu, M. ter Beest, F. Martin-Belmonte, A. Kierbel, J.  Engel, and K. Mostov.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1038/ncb146 1 Gauthier, N.C., M.A.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1126/science.109689 6 Insall, R.H., and O.D.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10   .1016/S1534-5807(01)00086- 7 Janetopoulos, C., and P. Devreotes.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
http://dx.doi.org/   10.1083/jcb.20060315 6Transfection of plasmids was performed using Fugene HD (Roche) ac - cording to the manufacturer’s protocol.,OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1146/annurev.cb.09.110193.00043 5 Schultz, C. 2003.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/S0968-0896(02)00552- 7 Schultz, C. 2010.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1038/nchembio.38 9 Schweisguth, F., J.A.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi   .org/10.1101/gad.4.6.92 2 Simpson, L., and E. Wieschaus.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/   10.1083/jcb.151.4.90 5 Sokac, A.M., and E. Wieschaus.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.02.01 4 Stambolic, V., A. Suzuki, J.L.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/S0092-8674   (00)81780- 8 Suh, B.C., T. Inoue, T. Meyer, and B. Hille.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"314:1454– 1457. http://dx.doi.org/10.1126/science.113116 3 Sullivan, W., and W.E.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/S0960-9822(00)00019- 1 Thomas, J.H., and E. Wieschaus.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1242/dev.0098 9 Uehara, R., G. Goshima, I. Mabuchi, R.D.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j.cub.2010.04.05 8 Varnai, P., B. Thyagarajan, T. Rohacs, and T. Balla.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1083/jcb.20060711 6 von Stein, W., A. Ramrath, A. Grimm, M. Müller-Borg, and A. Wodarz.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/   10.1242/dev.0172 0 Wieschaus, E., and D. Sweeton.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10   .1016/j.chembiol.2009.10.00 5 Lecuit, T., and F. Pilot.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi   .org/10.1038/ncb0203-10 3 Lecuit, T., and E. Wieschaus.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1083/jcb.150.4.84 9 Lee, D.M., and T.J. Harris.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j.cub.2013   .08.05 8 Levayer, R., and T. Lecuit.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi   .org/10.1016/j.tcb.2011.10.00 1 Martin, A.C., M. Kaschube, and E.F. Wieschaus.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1038/nature0752 2 Martin-Belmonte, F., A. Gassama, A. Datta, W. Yu, U. Rescher, V. Gerke, and  K. Mostov.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j.cell.2006.11.05 1 Mason, F.M., M. Tworoger, and A.C. Martin.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1038/ncb279 6 Mayer, B.J., R. Ren, K.L.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/   10.1126/scisignal.200283 9 Muthuswamy, S.K., M. Gilman, and J.S.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j.cub.2003.10.02 3 Pinal, N., D.C. Goberdhan, L. Collinson, Y. Fujita, I.M.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j.cub.2005   .11.06 8 Pollard, T.D.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j.ceb.2009.11.01 0 Putyrski, M., and C. Schultz.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi.org/10.1016/j   .febslet.2012.04.06 1 Rauzi, M., P.F.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"468:1110– 1114. http://dx.doi.org/10.1038/nature0956 6 Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi   .org/10.1038/nmeth.122 0 Royou, A., C. Field, J.C. Sisson, W. Sullivan, and R. Karess.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi   .org/10.1091/mbc.E03-06-044 0 Salbreux, G., G. Charras, and E. Paluch.",Non-OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
"http://dx.doi   .org/10.1016/j.tcb.2012.07.00 1 Schejter, E.D., and E. Wieschaus.",OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
http://dx.doi.org/10.1016/0092-8674(93)80078- S,OADS,/arxiv_data1/oa_pdf/8d/8f/JCB_201309079.PMC4018783.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
Online supplemental material is available at http://www.jcb.org/cgi/ content/full/jcb.201309096/DC1.,Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201309096.dv.,OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/   10.1093/jmicro/52.6.53 5 Ayalon, G., J.Q.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
